WO2017170970A1 - Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same - Google Patents

Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same Download PDF

Info

Publication number
WO2017170970A1
WO2017170970A1 PCT/JP2017/013489 JP2017013489W WO2017170970A1 WO 2017170970 A1 WO2017170970 A1 WO 2017170970A1 JP 2017013489 W JP2017013489 W JP 2017013489W WO 2017170970 A1 WO2017170970 A1 WO 2017170970A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
seafood
fish
controlling
Prior art date
Application number
PCT/JP2017/013489
Other languages
French (fr)
Japanese (ja)
Inventor
幸辰 藤田
博 横山
大樹 小川
Original Assignee
マルハニチロ株式会社
国立大学法人東京大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2017047531A external-priority patent/JP6343796B2/en
Application filed by マルハニチロ株式会社, 国立大学法人東京大学 filed Critical マルハニチロ株式会社
Priority to AU2017239880A priority Critical patent/AU2017239880B2/en
Priority to US16/089,226 priority patent/US10813914B2/en
Priority to KR1020187030805A priority patent/KR20180125565A/en
Priority to EP17775503.0A priority patent/EP3437642A4/en
Priority to MX2018011974A priority patent/MX2018011974A/en
Priority to CN201780021272.1A priority patent/CN108883095B/en
Publication of WO2017170970A1 publication Critical patent/WO2017170970A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • A01N43/521,3-Diazoles; Hydrogenated 1,3-diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/18Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention relates to a composition for controlling microspores of seafood and a method for controlling microspores of seafood using the same.
  • Microsporidia are a group of unicellular eukaryotes that parasitize the cells of various animals such as insects, crustaceans, seafood, and mammals, and many of them are pathogenic to these animals.
  • microsporeworms that are pathogenic to seafood, (1) Amberjack, Hamachi encephalomyelitis-causing microsporidia, (2) Heterosporis anguillarum, which causes downy mildew in cultured eels (3) Glugea plecoglossi, etc.
  • Buko becosis is an infectious disease of mojaco (brass fry) caused by the microsporidia Microsporidium seriolae, which is currently confirmed in Japan and Taiwan.
  • Mojaco is infected with Microsporidium seriolae
  • a cheese mass cyst (spore sac) that can be seen with the naked eye is formed in the muscle.
  • the fish body becomes uneven as the surrounding muscle tissue melts.
  • Beco's disease generally disappears with age, but part of it remains in the muscle at the time of shipment, which can greatly reduce the commercial value. For this reason, farmers have suffered significant economic losses.
  • even in cultured amberjack although the types of microsporidia that cause it are different, the occurrence of downy mildew has become a problem and the damage is on the rise.
  • Benzimidazole drugs are examples of drugs that have a high therapeutic effect on microsporidia in terrestrial animals including humans. For example, in an antibacterial activity test in a culture test, it has been reported that high antibacterial activity is observed for benzimidazole drugs or fumagillin against some microsporidia. In particular, albendazole (see the following formula) has been reported to exhibit high antibacterial activity against many microsporeworms (see Non-Patent Documents 3 to 7).
  • benzimidazole-containing drugs including albendazole have become the first choice for encephalistosis in rabbits caused by human microsporidia and microsporidia as the causative agent (see Non-Patent Document 8). ).
  • fumagillin which is an antibiotic against amoeba
  • Ayu gulgeosis causal pathogen is a kind of microsporidia belonging to the subfamily of Apansporoblast.
  • Glugea plecoglossi see Non-Patent Document 1
  • eel beko disease a high therapeutic effect was observed. Has been reported.
  • Benzimidazole drugs are approved in many countries as animal husbandry and human medicines for parasitic diseases. In Japan as well, as human body drugs, echinococcus control agent, escazole (main component: albendazole), as livestock medicine, facinex (main component: triclabendazole), roundworm, roundworm, whipworm Marine bantel (main component: fenbendazole (see the formula below) for trough puffer's aphids (heterobotulosis) as an insecticide, flumoxal (main component: fulbendazole), Maypol (main component: fenbendazole), and a marine product )) Is commercially available.
  • fumagillin is not approved as a human body medicine or animal husbandry because of its low safety against animals.
  • benzimidazole derivatives only changes in the protozoa morphology under a microscope after drug sensitization to the spiderfish gulgea disease have been confirmed.
  • glugea anomala is a microsporidia with a pathological condition that is distinctly different from the genus Microsporidium, which is susceptible to the action of drugs in the bath because it makes cysts mainly on the body surface of fish, and forms cysts in the muscles. For this reason, it is not an exaggeration to say that there is no information on the control effect against the genus Microspodium, which is the most important from the viewpoint of productivity for aquaculture business.
  • the present invention has been made in view of the above circumstances, and prevents the infection of sea urchin muscles or organs by microsporidia and / or suppresses the growth of microspores in seafood muscles or organs. And / or a composition for controlling microspores of seafood that is highly effective in controlling microsporeworms from the body of seafood and is excellent in safety, and control of microsporeworms of seafood using the same
  • the purpose is to provide a method that can be effectively used in industry.
  • a first aspect of the present invention that meets the above-described object is represented by the following general formula (I), prevents infection of microspores to muscles or organs of seafood and / or muscles or organs of seafood
  • An object of the present invention is to provide a composition for controlling microspores of fish and shellfish containing one or more selected from the group consisting of compounds that produce a compound represented by formula (I) as an active ingredient. It is.
  • R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N ⁇ CHR 9 , a functional group represented by the formula —N ⁇ CR 10 (R 11 ),
  • a functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group, R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected
  • the second aspect of the present invention is represented by the above general formula (I), prevents infection of microsporeworms to the muscles or organs of seafood and / or microscopically in the muscles or organs of seafood.
  • a compound having an activity of inhibiting the growth of spores and / or eliminating microsporeworms from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and metabolism in the body of fish and shellfish, the above general formula (I) By providing a method for controlling microsporeworms in fish and shellfish, comprising the step of administering to the fish and shellfish a composition comprising one or more selected from the group consisting of compounds that produce the compound represented by It solves the problem.
  • the composition is represented by the general formula (I).
  • the compound that produces the compound represented by the general formula (I) is represented by the following formula (8): )
  • the seafood is, for example, perch It may be a fish belonging to (Perciformes) or the flounder (Pleuronectiformes).
  • the fish and shellfish are periwinkle.
  • Tuna genus Thunnus
  • Persimmonidae Carangidae
  • Buri Buri
  • Persimmonidae Sparidae
  • Red sea bream Chorysophrys
  • Lepidoptera Paralichthyidae
  • Flatfish Paralichthys
  • flounder It may be a fish belonging to the genus Pleuronectidae (Verasper).
  • the microsporeworm is, for example, Microsporidium. It may be a microsporeworm belonging to the genus.
  • the microsporeworm is Microsporidium seriolae. There may be.
  • the composition may be, for example, an oral administration agent, a feed for fish farming, an injection, or a bath powder. Good.
  • control of microsporeworms means prevention of infection of microsporeworms, prevention of growth of microsporeworms that have entered (infected) the body of seafood, extermination and other muscles of A seafood Or it refers to the prevention of microspore invasion into organs and the management of the population (including extermination and killing).
  • the administration to the seafood may be oral administration.
  • the first of the present invention is an oral preparation.
  • the composition for controlling microspores of fish and shellfish according to the embodiment is applied once or a plurality of times at intervals of 1 day or more and 180 days or less so that the dose of the active ingredient is 0.1 mg / kg or more and 100 mg / kg or less.
  • the composition for controlling microsporeworms of fish and shellfish according to the first aspect of the present invention, which is an oral preparation may be effective for preventing the infection of fish and shellfish by oral administration.
  • the microsporeworms of fish and shellfish may be controlled by oral administration once or multiple times at intervals of 6 hours or more and 180 days or less so that the dose of the component is 20 mg / kg or more and 400 mg / kg or less. .
  • the composition for controlling microsporeworms of seafood according to the first aspect of the present invention which is an oral agent, is used as an active ingredient thereof. Even if the dose is 20 mg / kg or more and 400 mg / kg or less, it is administered orally several times at intervals of 3 days or more and 180 days or less to control the microsporidia of seafood and prevent reinfection. Good.
  • oral administration may be performed at intervals of 5 days or more and 21 days or less, and the plurality of oral administrations may be defined as one cycle, and the cycle may be repeated at intervals of 3 days or more and 180 days or less.
  • the administration to the seafood may be intramuscular injection or intraperitoneal injection.
  • the administration to the fish and shellfish may be immersion in a medicine bath, and in this case, it is a medicine bath.
  • Immersion in fish and shellfish in a medicinal bath solution containing the composition for controlling microspores of fish and shellfish according to the first aspect of the present invention in an amount such that the concentration of the active ingredient is 1 to 1000 ppm. Administration may be performed.
  • the present invention it is possible to prevent infection of microsporeworms in muscles or organs of seafood and / or suppress the growth of microsporeworms in muscles or organs of seafood, and / or the body of seafood.
  • the present invention provides a composition for controlling microspores of seafood that is highly effective in controlling microsporeworms and is excellent in safety, and a method for controlling microspores of seafood using the same.
  • composition for controlling microspores of seafood according to the first embodiment of the present invention (hereinafter sometimes referred to as “composition for controlling microspores of seafood” or simply “composition”) .) Is represented by the following general formula (I), and prevents the infection of fish and muscles or organs with microsporeworms and / or the growth of microspores in fish and shellfish muscles or organs: It is represented by the following general formula (I) by a compound having an activity of inhibiting and / or eliminating microsporeworms from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and metabolism in the body of fish and shellfish One or more selected from the group consisting of compounds that produce compounds (prodrugs) are included as active ingredients.
  • R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N ⁇ CHR 9 , a functional group represented by the formula —N ⁇ CR 10 (R 11 ),
  • a functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group, R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected
  • the substituted or unsubstituted alkyl group in the general formula (I) is preferably an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms. Included in the above general formula (I) are a substituted or unsubstituted alkylthio group, a substituted or unsubstituted acyl group, a substituted or unsubstituted alkoxyl group, and a substituted or unsubstituted alkyl sulfoxide group (alkylsulfinyl group).
  • the alkyl groups are each independently an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms.
  • the substituted or unsubstituted cycloalkyl group is preferably a cycloalkyl having 3 to 7 carbon atoms.
  • the substituted or unsubstituted aryl group in the above general formula is preferably a phenyl group.
  • a phenyl group is preferred.
  • a halogen atom can be mentioned as a substituent of an aryl group.
  • Examples of the substituted phenyl group include a 4-fluorophenyl group and a 2,3-dichlorophenyl group.
  • Examples of the acyl group having a substituted or unsubstituted aryl group include a phenylcarbonyl group and a 4-fluorophenylcarbonyl group.
  • An example of a substituted aryloxy group is a 2,3-dichlorophenyloxy group.
  • Examples of the alkylthio group include a methylsulfanyl group, an ethylsulfanyl group, and a propylsulfanyl group.
  • Examples of the arylthio group include a phenylthio group.
  • alkyl sulfoxide group examples include a methylsulfinyl group, an ethylsulfinyl group, and a propylsulfinyl group.
  • aryl sulfoxide group examples include a phenylsulfinyl group.
  • Benzimidazole is a compound composed of a complex ring of benzene and imidazole (benzimidazole ring) as shown in the general formula (I), and this skeleton is strong against tubulin in nematode and microsporidia cells. By binding, it is thought to exert an anthelmintic action by inhibiting the polymerization action of intracellular microtubules. Moreover, the difference in antibacterial activity is recognized by the difference in the functional group of a side chain (reference literature: E.Lacey. Mode of action of benzimidazoles. Parasitology Today 1990, 6, p112-115.).
  • the active ingredient of the control composition is a benzimidazole derivative, and the benzimidazole derivative containing a basic functional group such as an amino group or an acidic functional group such as a carboxylic acid group or a sulfonic acid group as a substituent.
  • Pharmaceutically acceptable salts and compounds that produce benzimidazole derivatives or pharmaceutically acceptable salts thereof by metabolism in the body of fish and shellfish (not necessarily containing a benzimidazole ring).
  • the active ingredient may be one of these, or a mixture containing any two or more of them in any proportion.
  • compositions include alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as magnesium salt and calcium salt, ammonium salt, acetate salt, propionate salt, butyrate salt, Organic acid salts such as lactate, tartrate, citrate, succinate, fumarate and maleate, inorganic acid salts such as hydrochloride, nitrate, sulfate, hydrogensulfate, carbonate, bicarbonate Is mentioned.
  • alkali metal salts such as sodium salt and potassium salt
  • alkaline earth metal salts such as magnesium salt and calcium salt
  • ammonium salt such as acetate salt, propionate salt, butyrate salt
  • Organic acid salts such as lactate, tartrate, citrate, succinate, fumarate and maleate
  • inorganic acid salts such as hydrochloride, nitrate, sulfate, hydrogensulfate, carbonate, bicarbonate Is mentioned.
  • the prodrug of the compound represented by the general formula (I), a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) include the following formula (1) ) To (10).
  • the compound of the formula (8) is an albendazole prodrug
  • the compound of the formula (9) is a fenbendazole prodrug.
  • fenbendazole represented by formula (1) albendazole represented by formula (3)
  • flubendazole represented by formula (6) and formula (10) are particularly preferable.
  • the target seafood is not particularly limited.
  • fish belonging to the order Perciformes or Pleuronectiformes and particularly belonging to the genus Scombridae, Thunnus, bluefin tuna, southern bluefin tuna , Bigeye, yellowfin, etc.
  • target microsporidia is not particularly limited, for example, it belongs to the genus Microsporidium, and in particular, Microsporidium seriolae, which is a causative agent of yellowtail rot.
  • composition for controlling microspores of seafood may take any form suitable for administration to seafood, and specific examples include oral preparations, injections, and bath preparations. .
  • These compositions may contain components other than at least one active ingredient selected from any pharmaceutically acceptable carrier, solvent, excipient, spreading agent and other additives.
  • Known or conventionally used carriers, solvents, excipients, spreading agents and other additives can be used.
  • it comprises a compound represented by general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that generates a compound represented by general formula (I) by metabolism in the body of fish and shellfish. At least one selected from the group can be used as an active ingredient of the composition for controlling microsporeworms.
  • a compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof and a compound that produces a compound represented by the general formula (I) by metabolism in the body of fish and shellfish.
  • At least one selected can be used as an active ingredient in the production of a composition for controlling microsporeworms.
  • the composition for controlling microsporidia at least one active ingredient selected from any of the above-mentioned pharmaceutically acceptable carriers, solvents, excipients, spreading agents and other additives. These ingredients may be blended. Therefore, this invention includes the usage method in manufacture of the composition for microspore insect control of such an active ingredient.
  • control method of microspores of fish and shellfish The method for controlling microspores of fish and shellfish according to the second embodiment of the present invention (hereinafter sometimes referred to as “control method of microspores of fish and shellfish” or simply “control method”).
  • control method of microspores of fish and shellfish Represented by the above general formula (I), preventing the infection of seafood muscles or organs with microsporeworms and / or suppressing the growth of microspores in seafood muscles or organs, and / or Or from a compound that has the activity of controlling microsporidia from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) by metabolism in the body of fish and shellfish
  • description is abbreviate
  • any administration method is particularly applicable as long as it can be applied to the seafood.
  • the administration method include oral administration, injection (intramuscular injection, intraperitoneal injection), and immersion administration in a drug bath.
  • administration in any form suitable for oral administration is possible, but it is convenient and preferable to ingest with feed in the form of inclusion in feed during feeding.
  • the dose, administration interval, and administration period are appropriately adjusted according to the target seafood, the type of microsporeworm to be controlled, and the purpose of administration (for example, prevention (infection prevention), extermination, etc.).
  • prevention prevention
  • extermination etc.
  • the composition is administered orally multiple times. By administering the composition for controlling microspores of fish and shellfish at such doses and intervals, the effect of preventing microspore infections is maintained for at least about 4 weeks after the end of the administration.
  • control of microsporidia it is orally administered once or multiple times at intervals of 6 hours or more and 180 days or less so that the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less.
  • the dose for each administration may be changed, and the administration interval may not be constant.
  • the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less, preferably 3 days or more and 180 days or less, more preferably 5 days or more and 21 days or less
  • the composition for controlling microspores of seafood may be orally administered multiple times.
  • the composition for controlling microspores of fish and shellfish is administered at such doses and intervals, the composition for controlling microspores of fish and shellfish per time increases, but between each time of administration
  • fish and shellfish will acquire immunity to microsporidia and the reinfection prevention effect of microsporidia will last for a long period of time, and the total dose of the composition for controlling microspores of seafood Can be reduced.
  • the plurality of oral administrations described above may be one cycle, and this administration cycle may be repeated at intervals of 3 days or more and 180 days or less.
  • the concentration of the active ingredient in the chemical bath solution is, for example, 0.1 to 1000 ppm.
  • the most preferable concentration and time are 10 mg / kg and 2 hours, but since the effect and toxicity differ depending on the water temperature, it is necessary to adjust while observing the state of the fish.
  • Administration may be single or multiple.
  • the concentration of the active ingredient in the chemical bath, the soaking time for each time, and the administration interval are appropriately adjusted according to the drug metabolism status of the target fish.
  • the administration interval may be constant as in the case of oral administration, or may be changed every time.
  • the concentration of the active ingredient in the injection solution is, for example, 1 mg to 300 mg / kg.
  • Administration may be single or multiple.
  • the most preferred concentration is 10 to 100 mg / kg, and the concentration of active ingredient and the administration interval may be constant as in the case of oral administration, or may be changed each time.
  • test group control group (test was conducted under the same conditions as described above except that the feed fed did not contain fenbendazole), fenbendazole group)
  • 10 mojakos were taken out from each of them and dropped into 3 pieces, and it was visually inspected for microsporeworm cysts (becocysts) in one body. If becocyst was observed, it was determined as positive and counted. The number of becocysts confirmed with the naked eye was confirmed, and the average number of infections per fish was determined.
  • Table 1 shows the inspection results.
  • the number of positives in the control group was 8 out of 10
  • the number of positives in the fenbendazole group was 6 out of 10 animals, and no significant difference was observed.
  • the average number of becocysts per fish is 8.0 ⁇ 5.20 for the control group, while it is 3.5 ⁇ 3.83 for the fenbendazole group. Significant differences were observed within 5%.
  • Table 2 shows the inspection results.
  • the prevention test was conducted according to the following procedure. ⁇ Test cage 5m ⁇ 5m ⁇ 5m ⁇ Number of test fish 1000 (starting weight 7g) ⁇ Administration method Oral administration (feeding with spreading agent) Test period 2 months Drug Albendazole (compound represented by the above formula (3)) ⁇ Dose 20mg / kg Bw (20mg per kg fish weight) ⁇ Dose interval 6 times / week
  • Sampling inspection was performed according to the following procedure. Every 2 weeks from the start of administration, 20 mojaco (100 fish in the 8th week after the start of administration) are picked up from each test group, dropped into 3 pieces, and microsporeworm cysts (becocysts) are observed on one side Inspect visually. If becocyst is found, it is determined as positive and counted. The number of becocysts confirmed with the naked eye is confirmed, and the average number of infections per animal is determined.
  • Table 4 shows the changes in the weight of Mojaco subjected to the test.
  • the dose and administration interval of albendazole per time are as described in 1-1.
  • the prevention of becopathic infection did not continue until 8 weeks after the end of the administration of albendazole, and the occurrence of becocysts was confirmed.
  • the end of the administration of albendazole It was confirmed that the occurrence of becocysts was greatly suppressed even after the lapse of 8 weeks (24 weeks after the start of administration).
  • the becocysts confirmed in Test Zone 2 are old and hardened and are not considered to have newly occurred after the administration of albendazole. From these results, it was suggested that the resistance to reinfection of Beco's disease was acquired in Test Group 2 by administering albendazole by a different administration method from Test Group 1.
  • the microsporeworm ⁇ -tubulin gene which is a pathogen of seafood shows a high homology with the microsporeworm ⁇ -tubulin gene sensitive to benzimidazole drugs, Furthermore, it can be presumed that a benzimidazole drug is highly likely to be a microsporeworm control drug for those whose codon 198 is glutamic acid. Therefore, the ⁇ -tubulin gene was isolated from microsporidia that were infectious to various fish and shellfish, amplified by PCR, sequencing and amino acid sequence confirmation. The results are shown in Table 10 below.
  • the amino acid sequence of ⁇ -tubulin from rabbit-derived microsporidia that is sensitive to benzimidazole drugs is highly homologous to the amino acid sequence of ⁇ -tubulin from yellowtail, amberjack, bluefin tuna, red sea bream, and flounder It was. Furthermore, the microsporeworm ⁇ -tubulin gene codon 198 derived from these fish was all glutamic acid (E). From the above test results, it was suggested that the microspores derived from red sea bream, hoshigarei and bluefin tuna may be sensitive to benzimidazole.
  • Example 2 Treatment test 2-1. Therapeutic test of downy mildew-infected mojaco using albendazole The therapeutic test was performed according to the following procedure. ⁇ Test cage 5m ⁇ 5m ⁇ 5m ⁇ Number of test fish: 100 (tests were conducted by selecting fish that were clearly infected with downy mildew by visual inspection at the time of vaccination) ⁇ Administration method Oral administration (feeding with spreading agent) Test period 2 months Drug Albendazole (compound represented by the above formula (3)) ⁇ Dose 50mg / kg Bw (50mg / kg fish weight) ⁇ Dose interval 6 times / week

Abstract

A composition for controlling microsporidia in fishes is prepared by using, as an active ingredient, at least one kind of compound selected from the group consisting of a compound represented by general formula (I) [wherein R2, R4, R5, R6 and R7 independently represent a specific substitute], a pharmaceutically acceptable salt thereof, and a compound capable of forming a compound represented by general formula (I) when metabolized in a fish body. Provided is a method for controlling microsporidia in fishes, said method comprising using the aforesaid composition for controlling microsporidia in fishes so as to exert excellent effects of preventing microsporidia infection in fish muscles or organs, and/or inhibiting the proliferation of microsporidia in fish muscles or organs, and/or exterminating microsporidia from fish bodies, and having high safety.

Description

魚介類の微胞子虫の防除用組成物及びそれを用いた魚介類の微胞子虫の防除方法Composition for controlling microspores of seafood and method for controlling microspores of seafood using the same
 本発明は、魚介類の微胞子虫の防除用組成物及びそれを用いた魚介類の微胞子虫の防除方法に関する。 The present invention relates to a composition for controlling microspores of seafood and a method for controlling microspores of seafood using the same.
 微胞子虫とは、昆虫、甲殻類、魚介類、ほ乳類等の様々な動物の細胞内に寄生する単細胞真核生物の一群で、これらの動物に対し病原性を示すものも多く存在する。魚介類に病原性を示す微胞子虫としては、
(1)カンパチ、ハマチの脳脊髄炎原因微胞子虫、
(2)養殖ウナギにベコ病を生じるHeterosporis anguillarum、
(3)アユのグルゲア症の原因となるGlugea plecoglossi等、
(4)ニジマスの武田微胞子虫症の原因となるMicrosporidium takedai、
(5)ブリのベコ病の原因となるMicrosporidium seriolae、
(6)養殖エビでの微胞子虫症であるEnterocytozoon hepatopenaei等
が知られている。
Microsporidia are a group of unicellular eukaryotes that parasitize the cells of various animals such as insects, crustaceans, seafood, and mammals, and many of them are pathogenic to these animals. As microsporeworms that are pathogenic to seafood,
(1) Amberjack, Hamachi encephalomyelitis-causing microsporidia,
(2) Heterosporis anguillarum, which causes downy mildew in cultured eels
(3) Glugea plecoglossi, etc. that cause Ayu gurugeosis
(4) Microsporidium takedai causing rainbow trout in Takeda microsporidia,
(5) Microsporidium seriolae that causes downy mildew
(6) Enterocytozoon hepatopenaei, which is microsporidia in cultured shrimp, is known.
 ブリ類のベコ病は、微胞子虫Microsporidium seriolaeを原因とするモジャコ(ブリの稚魚)の感染症であり、現在日本及び台湾で確認されている。モジャコがMicrosporidium seriolaeに感染すると、筋肉内に肉眼でも確認できるチーズ塊状のシスト(胞子嚢)が形成される。シストの形成が終わると、周辺の筋肉組織が融解するのに伴い、魚体に凹凸が認められるようになる。ベコ病は一般に、年齢と共に消失するが、出荷時に一部が筋肉内に残存し、大幅に商品価値を落とすことがある。このため養殖業者が大きな経済的損失を受けている。また、近年では、養殖カンパチでも、原因となる微胞子虫の種類は異なるものの、ベコ病の発生が問題化しており被害は拡大傾向にある。 Buko becosis is an infectious disease of mojaco (brass fry) caused by the microsporidia Microsporidium seriolae, which is currently confirmed in Japan and Taiwan. When Mojaco is infected with Microsporidium seriolae, a cheese mass cyst (spore sac) that can be seen with the naked eye is formed in the muscle. After the formation of the cysts, the fish body becomes uneven as the surrounding muscle tissue melts. Beco's disease generally disappears with age, but part of it remains in the muscle at the time of shipment, which can greatly reduce the commercial value. For this reason, farmers have suffered significant economic losses. In recent years, even in cultured amberjack, although the types of microsporidia that cause it are different, the occurrence of downy mildew has become a problem and the damage is on the rise.
 出荷後の養殖ブリ等においてベコ病が認められると、消費者からのクレーム、流通業者からの等級の格下げによる値引きの要求の原因となるだけでなく、最悪の場合には、取引停止に至るなど、養殖業者は深刻な打撃を蒙ることがある。さらに魚体重が4kgを超えると、外観からベコ病に罹患しているか否かについての判断が困難になるため、出荷時に防御の方法がない。 If downy mildew is found in cultured yellowtail after shipment, it will not only cause complaints from consumers and discount requests from graders from distributors, but in the worst case it will result in suspension of transactions. Farmers can be severely hit. Furthermore, if the fish weight exceeds 4 kg, it is difficult to determine whether or not the child suffers from downy mildew from the appearance. Therefore, there is no defense method at the time of shipment.
 ブリのベコ病が報告されてから25年以上が経過するが、有効な治療法、ブリ等のベコ病に効果が認められる治療薬やワクチンは存在せず、防除方法が確立されていないのが現状である。このため、飼育管理によって感染を軽度に止めることが現実的な対策となる。ベコ病の感染は、特定時期(5月~8月)のモジャコに集中し、それ以降ブリは殆ど感染を起こさないと考えられている。したがって、ワクチン接種時(5月~6月)に、外見的に体表の凹凸が認められたものを淘汰することが、唯一の現実的な対応である。ただし、ワクチン時の淘汰については、生体を処分するため歩留まりが減少することで経済的な損失を被る。さらに淘汰後の結果について科学的に検証されたデータはないため、効果について疑問が残る。 More than 25 years have passed since Beko's downy mildew was reported, but there are no effective treatments, no therapeutic drugs or vaccines that are effective against downy mildew such as yellowtail, and no control method has been established. Currently. For this reason, it is a realistic measure to stop infection mildly by breeding management. Beko disease infection is concentrated in Mojaco at a specific time (May-August), and yellowtail has been considered to cause little infection since then. Therefore, the only realistic response is to despise the appearance of irregularities on the body surface at the time of vaccination (May to June). However, as for the sputum at the time of vaccination, an economic loss is incurred due to a decrease in yield because the living body is disposed of. In addition, there are no scientifically validated data on the post-mortem results, so questions remain about the effects.
 実験的には、砂でろ過した海水を飼育水として使用した場合、ベコ病の発生が認められなかったとの報告があるが、規模や管理能力を勘案すると、野外の養殖現場で実施することは事実上不可能である。 Experimentally, it has been reported that when seawater filtered with sand was used as breeding water, there was no occurrence of downy mildew, but considering the scale and management ability, Virtually impossible.
 ベコ病の予防および治療方法の確立が遅れている他の原因として、ベコ病の詳細な生活環が不明なことが挙げられる。また、治療薬開発の隘路になっている要因として、原因微生物である微胞子虫の培養方法が確立されていないため、薬剤感受性試験が実施できず、候補被験薬を探索する合理的な方法が存在しないことが挙げられる。さらに、感染魚から得られた微胞子虫を直接他の魚に接種しても、感染が成立しないため、実験室内での効率的な感染実験ができない。以上のように、ベコ病について、防除対策のための基本的なデータをとる試験が実施できない。 Another reason for the late establishment of prevention and treatment methods for downy mildew is that the detailed life cycle of downy mildew is unknown. In addition, as a factor that has become a bottleneck in the development of therapeutic drugs, a method for culturing microsporeworms, which are the causative microorganisms, has not been established. It is mentioned that it does not exist. Furthermore, even if microsporeworms obtained from infected fish are directly inoculated into other fish, infection is not established, and therefore, efficient infection experiments in the laboratory cannot be performed. As described above, it is not possible to conduct a test for basic data for control measures for downy mildew.
 ヒトを含む陸上動物の微胞子虫症について高い治療効果が認められる薬剤として、ベンズイミダゾール系薬剤が挙げられる。例えば、培養試験における抗菌活性試験において、一部の微胞子虫に対し、ベンズイミダゾール系薬剤又はフマギリンに高い抗菌活性が認められることが報告されている。特に、アルベンダゾール(下式参照)が、多くの微胞子虫に対して高い抗菌活性を示すことが報告されている(非特許文献3~7参照)。 Benzimidazole drugs are examples of drugs that have a high therapeutic effect on microsporidia in terrestrial animals including humans. For example, in an antibacterial activity test in a culture test, it has been reported that high antibacterial activity is observed for benzimidazole drugs or fumagillin against some microsporidia. In particular, albendazole (see the following formula) has been reported to exhibit high antibacterial activity against many microsporeworms (see Non-Patent Documents 3 to 7).
Figure JPOXMLDOC01-appb-C000007
Figure JPOXMLDOC01-appb-C000007
 また、ヒト微胞子虫症や微胞子虫を原因病原体とするウサギのエンセファリストゾーン症には、アルベンダゾールを含むベンズイミダゾール系の薬剤が第一選択薬となっている(非特許文献8参照)。 In addition, benzimidazole-containing drugs including albendazole have become the first choice for encephalistosis in rabbits caused by human microsporidia and microsporidia as the causative agent (see Non-Patent Document 8). ).
 一方、魚類での微胞子虫対策での報告については、アメーバ等に対する抗生物質であるフマギリンを、アユのグルゲア症(原因病原体は、アパンスポロブラスト亜目に属する微胞子虫類の一種であるGlugea plecoglossi:非特許文献1参照)及びウナギのベコ病(原因病原体は、微胞子虫の一種であるHeterosporis anguillarum:非特許文献2参照)に対して投与した場合、高い治療効果が認められたことが報告されている。 On the other hand, as for the report on microsporidian countermeasures in fish, fumagillin, which is an antibiotic against amoeba, is used for Ayu gulgeosis (causative pathogen is a kind of microsporidia belonging to the subfamily of Apansporoblast. Glugea plecoglossi (see Non-Patent Document 1) and eel beko disease (causal pathogen is Heterosporis anguillarum: see Non-Patent Document 2), a high therapeutic effect was observed. Has been reported.
 Glugea anomalaを原因病原体とするトゲウオのグルゲア症で、ベンズイミダゾール系の物質で薬浴を実施した結果、病原寄生虫の顕微鏡下での崩壊が認められたことが報告されている。ただし、薬剤感作後の顕微鏡下における原虫の形態の変化が確認されているのみである。また、Glugea anomalaは主に魚の体表にシストを作るため、薬浴により薬の作用を受けやすく、筋肉内にシストを作るスズキ目のMicrosporidium属とは明らかに異なる病態の微胞子虫である(非特許文献9参照)。 It has been reported that, as a result of a medicinal bath with a benzimidazole-type substance, the decay of pathogenic parasites was observed under a microscope. However, only changes in the protozoa morphology under the microscope after drug sensitization have been confirmed. In addition, glugea anomala is a microsporidia with a pathology that is clearly different from the genus Microsporidium genus, which is susceptible to the action of drugs by a chemical bath and produces cysts in muscles, mainly because it makes cysts on the surface of fish. Non-patent document 9).
 ベンズイミダゾール系の薬剤については、多くの国で、寄生虫症に対する畜産薬及び人体薬として認可されている。我が国においても、人体薬としては、エキノコッカス駆除剤として、エスカゾール(主成分:アルベンダゾール)、畜産薬として肝蛭駆除剤としてファシネックス(主成分:トリクラベンダゾール)、回虫、円虫、鞭虫駆除剤のフルモキサール(主成分:フルベンダゾール)、メイポール(主成分:フェンベンダゾール)、水産薬として、トラフグのエラムシ(ヘテロボツリウム症)に対する、マリンバンテル(主成分:フェンベンダゾール(下式参照))が市販されている。 Benzimidazole drugs are approved in many countries as animal husbandry and human medicines for parasitic diseases. In Japan as well, as human body drugs, echinococcus control agent, escazole (main component: albendazole), as livestock medicine, facinex (main component: triclabendazole), roundworm, roundworm, whipworm Marine bantel (main component: fenbendazole (see the formula below) for trough puffer's aphids (heterobotulosis) as an insecticide, flumoxal (main component: fulbendazole), Maypol (main component: fenbendazole), and a marine product )) Is commercially available.
Figure JPOXMLDOC01-appb-C000008
Figure JPOXMLDOC01-appb-C000008
 しかしながら、フマギリンは動物に対する安全性が低いため、人体薬及び畜産薬として認可されていない。ベンゾイミダゾール誘導体についても、トゲウオのグルゲア病に対する薬剤感作後の顕微鏡下における原虫の形態の変化が確認されているのみである。さらに、Glugea anomalaは主に魚の体表にシストを作るため、薬浴により薬の作用を受けやすく、筋肉内にシストを作るスズキ目のMicrosporidium属とは明らかに異なる病態の微胞子虫である。このため養殖事業にとって生産性の観点から、最も重要であるスズキ目のMicrospodium属感染に対する防除効果の情報については、皆無であると言って過言ではない。 However, fumagillin is not approved as a human body medicine or animal husbandry because of its low safety against animals. As for benzimidazole derivatives, only changes in the protozoa morphology under a microscope after drug sensitization to the spiderfish gulgea disease have been confirmed. In addition, glugea anomala is a microsporidia with a pathological condition that is distinctly different from the genus Microsporidium, which is susceptible to the action of drugs in the bath because it makes cysts mainly on the body surface of fish, and forms cysts in the muscles. For this reason, it is not an exaggeration to say that there is no information on the control effect against the genus Microspodium, which is the most important from the viewpoint of productivity for aquaculture business.
 本発明はかかる事情に鑑みてなされたもので、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する効果が高く、安全性にも優れた魚介類の微胞子虫の防除用組成物及びそれを用いた魚介類の微胞子虫の防除し、産業上有効活用できる方法を提供することを目的とする。 The present invention has been made in view of the above circumstances, and prevents the infection of sea urchin muscles or organs by microsporidia and / or suppresses the growth of microspores in seafood muscles or organs. And / or a composition for controlling microspores of seafood that is highly effective in controlling microsporeworms from the body of seafood and is excellent in safety, and control of microsporeworms of seafood using the same The purpose is to provide a method that can be effectively used in industry.
 前記目的に沿う本発明の第1の態様は、下記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により前記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を有効成分として含む魚介類の微胞子虫の防除用組成物を提供することにより上記課題を解決するものである。 A first aspect of the present invention that meets the above-described object is represented by the following general formula (I), prevents infection of microspores to muscles or organs of seafood and / or muscles or organs of seafood A compound having an activity of inhibiting the growth of microsporeworms and / or controlling microsporeworms from the body of fish and shellfish, its pharmaceutically acceptable salt, and metabolism in the body of fish and shellfish An object of the present invention is to provide a composition for controlling microspores of fish and shellfish containing one or more selected from the group consisting of compounds that produce a compound represented by formula (I) as an active ingredient. It is.
Figure JPOXMLDOC01-appb-C000009
Figure JPOXMLDOC01-appb-C000009
 なお、上記一般式(I)において、
 Rは、アミノ基、式-NH-COORで表される官能基、式-N=CHRで表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
 R、R、Rは、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
 Rは、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基(アルキルスルフィニル基)、アリールスルホキシド基(アリールスルフィニル基)、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基(置換アルキルスルフィニル基)、置換アリールスルホキシド基(置換アリールスルフィニル基)、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
 R、R、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
In the general formula (I),
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group (an alkylsulfinyl group), an aryl sulfoxide group (an arylsulfinyl group), Acyl group, substituted alkoxyl group, substituted alkylthio group, substituted alkyl sulfoxide group (substituted alkylsulfinyl group), substituted aryl sulfoxide group (substituted arylsulfinyl group), substituted acyl group, halogen group, aryloxy group, substituted aryloxy group and R An atom or a functional group selected from the group consisting of 13 —CO—NH— (R 13 is an alkyl group);
R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
 本発明の第2の態様は、上記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により前記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を有効成分として含む組成物を魚介類に投与する工程を含む魚介類の微胞子虫の防除方法を提供することにより上記課題を解決するものである。 The second aspect of the present invention is represented by the above general formula (I), prevents infection of microsporeworms to the muscles or organs of seafood and / or microscopically in the muscles or organs of seafood. A compound having an activity of inhibiting the growth of spores and / or eliminating microsporeworms from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and metabolism in the body of fish and shellfish, the above general formula (I) By providing a method for controlling microsporeworms in fish and shellfish, comprising the step of administering to the fish and shellfish a composition comprising one or more selected from the group consisting of compounds that produce the compound represented by It solves the problem.
 本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物及び本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記一般式(I)で表される化合物が、下記の式(1)から(7)及び(10)で表される化合物のいずれかであり、前記一般式(I)で表される化合物を生成する化合物が下記の式(8)及び(9)で表される化合物のいずれかであってもよい。 In the composition for controlling microsporeworms of seafood according to the first aspect of the present invention and the method for controlling microsporeworms of seafood according to the second aspect of the present invention, the composition is represented by the general formula (I). Is a compound represented by the following formulas (1) to (7) and (10), and the compound that produces the compound represented by the general formula (I) is represented by the following formula (8): ) And any of the compounds represented by (9).
Figure JPOXMLDOC01-appb-C000010
Figure JPOXMLDOC01-appb-C000010
 本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物及び本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記魚介類が、例えば、スズキ目(Perciformes)又はカレイ目(Pleuronectiformes)に属する魚類であってもよい。 In the composition for controlling microsporeworms of seafood according to the first aspect of the present invention and the method for controlling microsporeworms of seafood according to the second aspect of the present invention, the seafood is, for example, perch It may be a fish belonging to (Perciformes) or the flounder (Pleuronectiformes).
 本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物及び本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記魚介類が、スズキ目サバ科(Scombridae)マグロ属(Thunnus)、スズキ目アジ科(Carangidae)ブリ属(Seriola)、スズキ目タイ科(Sparidae)マダイ属(Chrysophrys)、カレイ目ヒラメ科(Paralichthyidae)ヒラメ属(Paralichthys)又はカレイ目カレイ科(Pleuronectidae)マツカワ属(Verasper)に属する魚類であってもよい。 In the composition for controlling microspores of fish and shellfish according to the first aspect of the present invention and the method for controlling microsporeworms of seafood according to the second aspect of the present invention, the fish and shellfish are periwinkle. (Scombridae) Tuna genus (Thunnus), Persimmonidae (Carangidae) Buri (Seriola), Persimmonidae (Sparidae) Red sea bream (Chrysophrys), Lepidoptera (Paralichthyidae) Flatfish (Paralichthys) or flounder It may be a fish belonging to the genus Pleuronectidae (Verasper).
 本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物及び本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記微胞子虫が、例えば、Microsporidium属に属する微胞子虫であってもよい。 In the composition for controlling microspores of fish and shellfish according to the first aspect of the present invention and the method for controlling microspores of seafood according to the second aspect of the present invention, the microsporeworm is, for example, Microsporidium. It may be a microsporeworm belonging to the genus.
 本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物及び本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記微胞子虫が、Microsporidium seriolaeであってもよい。 In the composition for controlling microspores of seafood according to the first aspect of the present invention and the method for controlling microspores of seafood according to the second aspect of the present invention, the microsporeworm is Microsporidium seriolae. There may be.
 本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物において、前記組成物は、例えば、経口投与剤、養魚用飼料、注射剤及び薬浴剤のいずれかであってもよい。 In the composition for controlling microspores of fish and shellfish according to the first aspect of the present invention, the composition may be, for example, an oral administration agent, a feed for fish farming, an injection, or a bath powder. Good.
 なお、本発明において、「微胞子虫の防除」とは、微胞子虫の感染の予防、魚介類の体内に侵入(感染)した微胞子虫の増殖の防止、駆除その他のA魚介類の筋肉又は臓器への微胞子虫の侵入の防止及び個体数の管理(駆除や殺滅も含む)を行うことをいう。 In the present invention, “control of microsporeworms” means prevention of infection of microsporeworms, prevention of growth of microsporeworms that have entered (infected) the body of seafood, extermination and other muscles of A seafood Or it refers to the prevention of microspore invasion into organs and the management of the population (including extermination and killing).
 本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記魚介類への投与が、経口投与であってもよく、この場合において、経口剤である本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物を、その有効成分の用量が0.1mg/kg以上100mg/kg以下となるよう、単回或いは1日以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫感染を予防するものであってもよく、経口剤である本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物を、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、単回或いは6時間以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫を駆除するものであってもよい。 In the method for controlling microsporeworms of seafood according to the second aspect of the present invention, the administration to the seafood may be oral administration. In this case, the first of the present invention is an oral preparation. The composition for controlling microspores of fish and shellfish according to the embodiment is applied once or a plurality of times at intervals of 1 day or more and 180 days or less so that the dose of the active ingredient is 0.1 mg / kg or more and 100 mg / kg or less. The composition for controlling microsporeworms of fish and shellfish according to the first aspect of the present invention, which is an oral preparation, may be effective for preventing the infection of fish and shellfish by oral administration. The microsporeworms of fish and shellfish may be controlled by oral administration once or multiple times at intervals of 6 hours or more and 180 days or less so that the dose of the component is 20 mg / kg or more and 400 mg / kg or less. .
 本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、経口剤である本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物を、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、3日以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫の駆除及び再感染の予防を行うものであってもよい。この場合において、5日以上21日以下の間隔で経口投与してもよく、前記複数回の経口投与を1サイクルとし、前記サイクルを、3日以上180日以下の間隔で反復してもよい。 In the method for controlling microsporeworms of seafood according to the second aspect of the present invention, the composition for controlling microsporeworms of seafood according to the first aspect of the present invention, which is an oral agent, is used as an active ingredient thereof. Even if the dose is 20 mg / kg or more and 400 mg / kg or less, it is administered orally several times at intervals of 3 days or more and 180 days or less to control the microsporidia of seafood and prevent reinfection. Good. In this case, oral administration may be performed at intervals of 5 days or more and 21 days or less, and the plurality of oral administrations may be defined as one cycle, and the cycle may be repeated at intervals of 3 days or more and 180 days or less.
 本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記魚介類への投与が、筋肉注射又は腹腔内注射であってもよい。 In the method for controlling microspores of seafood according to the second aspect of the present invention, the administration to the seafood may be intramuscular injection or intraperitoneal injection.
 本発明の第2の態様に係る魚介類の微胞子虫の防除方法において、前記魚介類への投与が、薬浴中での浸漬投与であってもよく、この場合において、薬浴剤である本発明の第1の態様に係る魚介類の微胞子虫の防除用組成物を、その有効成分の濃度が1から1000ppmとなる量だけ含有している薬浴液中で、魚介類への浸漬投与を行ってもよい。 In the method for controlling microspores of fish and shellfish according to the second aspect of the present invention, the administration to the fish and shellfish may be immersion in a medicine bath, and in this case, it is a medicine bath. Immersion in fish and shellfish in a medicinal bath solution containing the composition for controlling microspores of fish and shellfish according to the first aspect of the present invention in an amount such that the concentration of the active ingredient is 1 to 1000 ppm. Administration may be performed.
 本発明によると、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する効果が高く、安全性にも優れた魚介類の微胞子虫の防除用組成物及びそれを用いた魚介類の微胞子虫の防除方法が提供される。 According to the present invention, it is possible to prevent infection of microsporeworms in muscles or organs of seafood and / or suppress the growth of microsporeworms in muscles or organs of seafood, and / or the body of seafood. The present invention provides a composition for controlling microspores of seafood that is highly effective in controlling microsporeworms and is excellent in safety, and a method for controlling microspores of seafood using the same.
 続いて、本発明を具体化した実施の形態につき説明し、本発明の理解に供する。 Subsequently, an embodiment of the present invention will be described to provide an understanding of the present invention.
[第1の実施の形態]
 本発明の第1の実施の形態に係る魚介類の微胞子虫の防除用組成物(以下、「魚介類の微胞子虫の防除用組成物」又は単に「組成物」と略称する場合がある。)は、下記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により下記の一般式(I)で表される化合物を生成する化合物(プロドラッグ)からなる群より選択される1又は複数を有効成分として含んでいる。
[First Embodiment]
Composition for controlling microspores of seafood according to the first embodiment of the present invention (hereinafter sometimes referred to as “composition for controlling microspores of seafood” or simply “composition”) .) Is represented by the following general formula (I), and prevents the infection of fish and muscles or organs with microsporeworms and / or the growth of microspores in fish and shellfish muscles or organs: It is represented by the following general formula (I) by a compound having an activity of inhibiting and / or eliminating microsporeworms from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and metabolism in the body of fish and shellfish One or more selected from the group consisting of compounds that produce compounds (prodrugs) are included as active ingredients.
Figure JPOXMLDOC01-appb-C000011
Figure JPOXMLDOC01-appb-C000011
 なお、上記一般式(I)において、
 Rは、アミノ基、式-NH-COORで表される官能基、式-N=CHRで表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
 R、R、Rは、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
 Rは、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基(アルキルスルフィニル基)、アリールスルホキシド基(アリールスルフィニル基)、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基(置換アルキルスルフィニル基)、置換アリールスルホキシド基(置換アリールスルフィニル基)、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
 R、R、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
 上記一般式(I)における置換または未置換のアルキル基としては、炭素数1~6、好ましくは炭素数1~3のアルキル基が好ましい。
 上記一般式(I)における、置換または未置換のアルキルチオ基、置換または未置換のアシル基、置換または未置換のアルコキシル基、並びに、置換または未置換のアルキルスルホキシド基(アルキルスルフィニル基)に含まれるアルキル基はそれぞれ独立して炭素数1~6、好ましくは炭素数1~3のアルキル基が好ましい。
 置換または未置換のシクロアルキル基としては、炭素数3~7のシクロアルキルが好ましい。
 上記一般式における置換または未置換のアリール基としては、フェニル基が好ましい。
 上記一般式(I)における置換または未置換のアリールオキシ基、置換または未置換のアシル基、置換または未置換のアリールチオ基、置換または未置換のアリールスルホキシド基(アリールスルファニル基)のアリール基としては、フェニル基が好ましい。
 アリール基の置換基としては、ハロゲン原子を挙げることができる。
 置換フェニル基としては、4-フルオロフェニル基、2,3-ジクロロフェニル基を挙げることができる。
 置換または未置換のアリール基を有するアシル基としては、フェニルカルボニル基、4-フルオロフェニルカルボニル基を挙げることができる。
 置換アリールオキシ基としては、2,3-ジクロロフェニルオキシ基を挙げることができる。
 アルキルチオ基としては、メチルスルファニル基、エチルスルファニル基及びプロピルスルファニル基を挙げることができる。
 アリールチオ基としては、フェニルチオ基を挙げることができる。
 アルキルスルホキシド基(アルキルスルフィニル基)としては、メチルスルスルフィニル基、エチルスルフィニル基、プロピルスルフィニル基を挙げることができる。
 アリールスルホキシド基(アリールスルフィニル基)としては、フェニルスルフィニル基を挙げることができる。
In the general formula (I),
R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group (an alkylsulfinyl group), an aryl sulfoxide group (an arylsulfinyl group), Acyl group, substituted alkoxyl group, substituted alkylthio group, substituted alkyl sulfoxide group (substituted alkylsulfinyl group), substituted aryl sulfoxide group (substituted arylsulfinyl group), substituted acyl group, halogen group, aryloxy group, substituted aryloxy group and R An atom or a functional group selected from the group consisting of 13 —CO—NH— (R 13 is an alkyl group);
R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
The substituted or unsubstituted alkyl group in the general formula (I) is preferably an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms.
Included in the above general formula (I) are a substituted or unsubstituted alkylthio group, a substituted or unsubstituted acyl group, a substituted or unsubstituted alkoxyl group, and a substituted or unsubstituted alkyl sulfoxide group (alkylsulfinyl group). The alkyl groups are each independently an alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms.
The substituted or unsubstituted cycloalkyl group is preferably a cycloalkyl having 3 to 7 carbon atoms.
The substituted or unsubstituted aryl group in the above general formula is preferably a phenyl group.
As the aryl group of the substituted or unsubstituted aryloxy group, substituted or unsubstituted acyl group, substituted or unsubstituted arylthio group, substituted or unsubstituted aryl sulfoxide group (arylsulfanyl group) in the above general formula (I), A phenyl group is preferred.
A halogen atom can be mentioned as a substituent of an aryl group.
Examples of the substituted phenyl group include a 4-fluorophenyl group and a 2,3-dichlorophenyl group.
Examples of the acyl group having a substituted or unsubstituted aryl group include a phenylcarbonyl group and a 4-fluorophenylcarbonyl group.
An example of a substituted aryloxy group is a 2,3-dichlorophenyloxy group.
Examples of the alkylthio group include a methylsulfanyl group, an ethylsulfanyl group, and a propylsulfanyl group.
Examples of the arylthio group include a phenylthio group.
Examples of the alkyl sulfoxide group (alkylsulfinyl group) include a methylsulfinyl group, an ethylsulfinyl group, and a propylsulfinyl group.
Examples of the aryl sulfoxide group (arylsulfinyl group) include a phenylsulfinyl group.
 ベンズイミダゾールは、上記一般式(I)に示したように、ベンゼンとイミダゾールの複合環(ベンズイミダゾール環)からなる化合物であり、この骨格が線虫や微胞子虫の細胞中のチューブリンに強く結合することにより、細胞内の微小管の重合作用を阻害することにより駆虫作用を及ぼすと考えられている。また側鎖の官能基の違いにより抗菌活性の違いが認められている(参考文献:E.Lacey. Mode of action of benzimidazoles. Parasitology Today 1990, 6, p112-115.)。 Benzimidazole is a compound composed of a complex ring of benzene and imidazole (benzimidazole ring) as shown in the general formula (I), and this skeleton is strong against tubulin in nematode and microsporidia cells. By binding, it is thought to exert an anthelmintic action by inhibiting the polymerization action of intracellular microtubules. Moreover, the difference in antibacterial activity is recognized by the difference in the functional group of a side chain (reference literature: E.Lacey. Mode of action of benzimidazoles. Parasitology Today 1990, 6, p112-115.).
 防除用組成物の有効成分としては、ベンズイミダゾール誘導体、置換基として、アミノ基等の塩基性官能基やカルボン酸基やスルホン酸基等の酸性官能基を含むベンズイミダゾール誘導体については、それらの薬学的に許容される塩、魚介類の体内での代謝によりベンズイミダゾール誘導体又はそれらの薬学的に許容される塩を生成する化合物(必ずしもベンズイミダゾール環を含んでいなくてもよい。)が挙げられる。有効成分は、これらのうち1種であってもよく、任意の2種以上を任意の割合で含む混合物であってもよい。 The active ingredient of the control composition is a benzimidazole derivative, and the benzimidazole derivative containing a basic functional group such as an amino group or an acidic functional group such as a carboxylic acid group or a sulfonic acid group as a substituent. Pharmaceutically acceptable salts and compounds that produce benzimidazole derivatives or pharmaceutically acceptable salts thereof by metabolism in the body of fish and shellfish (not necessarily containing a benzimidazole ring). . The active ingredient may be one of these, or a mixture containing any two or more of them in any proportion.
 薬学的に許容される塩の具体例としては、ナトリウム塩、カリウム塩等のアルカリ金属塩、マグネシウム塩、カルシウム塩等のアルカリ土類金属塩、アンモニウム塩、酢酸塩、プロピオン酸塩、酪酸塩、乳酸塩、酒石酸塩、クエン酸塩、コハク酸塩、フマル酸塩、マレイン酸塩等の有機酸塩、塩酸塩、硝酸塩、硫酸塩、硫酸水素塩、炭酸塩、炭酸水素塩等の無機酸塩が挙げられる。 Specific examples of pharmaceutically acceptable salts include alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as magnesium salt and calcium salt, ammonium salt, acetate salt, propionate salt, butyrate salt, Organic acid salts such as lactate, tartrate, citrate, succinate, fumarate and maleate, inorganic acid salts such as hydrochloride, nitrate, sulfate, hydrogensulfate, carbonate, bicarbonate Is mentioned.
 上記一般式(I)で表される化合物、その薬学的に許容される塩及び上記一般式(I)で表される化合物を生成する化合物のプロドラッグの好ましい例としては、下記の式(1)から(10)で表される化合物が挙げられる。
 なお、式(8)の化合物はアルベンダゾールのプロドラックであり、式(9)の化合物は、フェンベンダゾールのプロドラックである。
Preferable examples of the prodrug of the compound represented by the general formula (I), a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) include the following formula (1) ) To (10).
The compound of the formula (8) is an albendazole prodrug, and the compound of the formula (9) is a fenbendazole prodrug.
Figure JPOXMLDOC01-appb-C000012
Figure JPOXMLDOC01-appb-C000012
 これらのうち、特に好ましいのは、式(1)で表されるフェンベンダゾール、式(3)で表されるアルベンダゾール、式(6)で表されるフルベンダゾール、式(10)で表されるトリクラベンダゾールである。 Of these, fenbendazole represented by formula (1), albendazole represented by formula (3), flubendazole represented by formula (6), and formula (10) are particularly preferable. Triclabendazole.
 対象となる魚介類は特に制限されないが、例えば、スズキ目(Perciformes)又はカレイ目(Pleuronectiformes)に属する魚類であり、特に、スズキ目サバ科(Scombridae)マグロ属(Thunnus)に属する、クロマグロ、ミナミマグロ、メバチ、キハダ等、スズキ目アジ科(Carangidae)ブリ属(Seriola)に属するブリ、カンパチ、ヒラマサ、スズキ目タイ科(Sparidae)マダイ属(Chrysophrys)に属するマダイ、アオボシマダイ、カレイ目ヒラメ科(Paralichthyidae)ヒラメ属(Paralichthys)に属するヒラメ、カレイ目カレイ科(Pleuronectidae)マツカワ属(Verasper)に属するホシガレイが挙げられる。 The target seafood is not particularly limited. For example, fish belonging to the order Perciformes or Pleuronectiformes, and particularly belonging to the genus Scombridae, Thunnus, bluefin tuna, southern bluefin tuna , Bigeye, yellowfin, etc., Periphyceae (Carangidae) belonging to the genus Seriola, Amberjack, Hiramasa, Persimmonidae (Sparidae), Red sea bream (Chrysophrys), Red sea bream, Flatfish, Paralechthyidae ) Flatfish belonging to the genus Paralichthys, Hoshigarei belonging to the genus Pleuronectidae and Verasper.
 対象となる微胞子虫は特に制限されないが、例えば、Microsporidium属に属するものであり、特に、ブリのベコ病の原因病原体であるMicrosporidium seriolaeが挙げられる。 Although the target microsporidia is not particularly limited, for example, it belongs to the genus Microsporidium, and in particular, Microsporidium seriolae, which is a causative agent of yellowtail rot.
 魚介類の微胞子虫の防除用組成物は、魚介類への投与に適した任意の形態をとるものであってよいが、具体例としては、経口剤、注射剤、薬浴剤が挙げられる。これらの組成物は、薬学的に許容される任意の担体、溶媒、賦形剤、展着剤及びその他の添加剤から選択される少なくとも1種の有効成分以外の成分を含んでいてもよい。公知の、あるいは従来使用されてきた、担体、溶媒、賦形剤、展着剤及びその他の添加剤を利用することができる。
 上記の通り、一般式(I)で表される化合物及びその薬学的に許容される塩、並びに、魚介類の体内での代謝により一般式(I)で表される化合物を生成する化合物からなる群から選択された少なくとも1種は、微胞子虫防除用組成物の有効成分として使用することができる。従って、一般式(I)で表される化合物及びその薬学的に許容される塩、並びに、魚介類の体内での代謝により一般式(I)で表される化合物を生成する化合物からなる群から選択された少なくとも1種は、微胞子虫防除用組成物の製造における有効成分として使用することができる。この微胞子虫防除用組成物の製造においては、上述した薬学的に許容される任意の担体、溶媒、賦形剤、展着剤及びその他の添加剤から選択される少なくとも1種の有効成分以外の成分を配合してもよい。従って、本発明は、かかる有効成分の微胞子虫防除用組成物の製造における使用方法を含む。
The composition for controlling microspores of seafood may take any form suitable for administration to seafood, and specific examples include oral preparations, injections, and bath preparations. . These compositions may contain components other than at least one active ingredient selected from any pharmaceutically acceptable carrier, solvent, excipient, spreading agent and other additives. Known or conventionally used carriers, solvents, excipients, spreading agents and other additives can be used.
As described above, it comprises a compound represented by general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that generates a compound represented by general formula (I) by metabolism in the body of fish and shellfish. At least one selected from the group can be used as an active ingredient of the composition for controlling microsporeworms. Therefore, from the group consisting of a compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that produces a compound represented by the general formula (I) by metabolism in the body of fish and shellfish. At least one selected can be used as an active ingredient in the production of a composition for controlling microsporeworms. In the production of the composition for controlling microsporidia, at least one active ingredient selected from any of the above-mentioned pharmaceutically acceptable carriers, solvents, excipients, spreading agents and other additives. These ingredients may be blended. Therefore, this invention includes the usage method in manufacture of the composition for microspore insect control of such an active ingredient.
[第2の実施の形態]
 本発明の第2の実施の形態に係る魚介類の微胞子虫の防除方法(以下、「魚介類の微胞子虫の防除方法」又は単に「防除方法」と略称する場合がある。)は、前記一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により前記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を魚介類に投与する工程を含んでいる。なお、本発明の第1の実施の形態に係る魚介類の微胞子虫の防除用組成物の説明と重複する事項については、説明を省略する。
[Second Embodiment]
The method for controlling microspores of fish and shellfish according to the second embodiment of the present invention (hereinafter sometimes referred to as “control method of microspores of fish and shellfish” or simply “control method”). Represented by the above general formula (I), preventing the infection of seafood muscles or organs with microsporeworms and / or suppressing the growth of microspores in seafood muscles or organs, and / or Or from a compound that has the activity of controlling microsporidia from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) by metabolism in the body of fish and shellfish A step of administering one or more selected from the group to seafood. In addition, about the matter which overlaps with description of the composition for controlling the microsporeworm of the seafood concerning the 1st Embodiment of this invention, description is abbreviate | omitted.
 魚介類の微胞子虫の防除方法において用いることができる魚介類の微胞子虫の防除用組成物の魚介類への投与方法は、魚介類に適用できるものである限り、任意の投与方法を特に制限なく用いることができる。投与方法の具体例としては、経口投与、注射(筋肉注射、腹腔内注射)、薬浴への浸漬投与等が挙げられる。 As for the administration method to the seafood of the composition for controlling the microspores of the seafood that can be used in the method for controlling the microspores of the seafood, any administration method is particularly applicable as long as it can be applied to the seafood. Can be used without limitation. Specific examples of the administration method include oral administration, injection (intramuscular injection, intraperitoneal injection), and immersion administration in a drug bath.
 経口投与の場合、経口投与に適した任意の形態での投与が可能であるが、給餌の際に飼料に含有させる形で飼料と共に摂取させることが簡便で好ましい。投与量、投与間隔及び投与期間については、対象となる魚介類、防除対象となる微胞子虫の種類、投与目的(例えば、予防(感染防止)、駆除等)により適宜調節されるが、例えば、微胞子虫の予防の場合、その有効成分の用量が0.1mg/kg以上100mg/kg以下となるよう、単回或いは1日以上180日以下の間隔で、魚介類の微胞子虫の防除用組成物を複数回経口投与する。このような用量及び間隔で魚介類の微胞子虫の防除用組成物の投与を行うことにより、投与終了後、少なくとも4週間程度にわたり、微胞子虫の感染の予防効果が持続する。 In the case of oral administration, administration in any form suitable for oral administration is possible, but it is convenient and preferable to ingest with feed in the form of inclusion in feed during feeding. The dose, administration interval, and administration period are appropriately adjusted according to the target seafood, the type of microsporeworm to be controlled, and the purpose of administration (for example, prevention (infection prevention), extermination, etc.). For the prevention of microsporeworms, for the control of microsporeworms of seafood at a single time or at intervals of 1 day or more and 180 days or less so that the dose of the active ingredient is 0.1 mg / kg or more and 100 mg / kg or less. The composition is administered orally multiple times. By administering the composition for controlling microspores of fish and shellfish at such doses and intervals, the effect of preventing microspore infections is maintained for at least about 4 weeks after the end of the administration.
 微胞子虫の駆除の場合、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、単回或いは6時間以上180日以下の間隔で複数回経口投与する。複数回投与する場合、各回毎の用量を変化させてもよく、投与間隔も一定でなくてもよい。 In the case of control of microsporidia, it is orally administered once or multiple times at intervals of 6 hours or more and 180 days or less so that the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less. In the case of multiple administrations, the dose for each administration may be changed, and the administration interval may not be constant.
 微胞子虫の駆除及び再感染予防の場合、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、3日以上180日以下、より好ましくは5日以上21日以下の間隔で、魚介類の微胞子虫の防除用組成物を複数回経口投与してもよい。このような用量及び間隔で魚介類の微胞子虫の防除用組成物の投与を行う場合、1回あたりの魚介類の微胞子虫の防除用組成物は多くなるが、各回毎の投与の間に、魚介類が微胞子虫に対する免疫を獲得し、微胞子虫の再感染予防効果が長期間にわたり持続することが期待されると共に、魚介類の微胞子虫の防除用組成物の合計投与量を低減させることができる。この場合において、上記の複数回の経口投与を1サイクルとし、この投与サイクルを、3日以上180日以内の間隔で反復してもよい。 In the case of controlling microsporidia and preventing reinfection, the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less, preferably 3 days or more and 180 days or less, more preferably 5 days or more and 21 days or less, The composition for controlling microspores of seafood may be orally administered multiple times. When the composition for controlling microspores of fish and shellfish is administered at such doses and intervals, the composition for controlling microspores of fish and shellfish per time increases, but between each time of administration In addition, it is expected that fish and shellfish will acquire immunity to microsporidia and the reinfection prevention effect of microsporidia will last for a long period of time, and the total dose of the composition for controlling microspores of seafood Can be reduced. In this case, the plurality of oral administrations described above may be one cycle, and this administration cycle may be repeated at intervals of 3 days or more and 180 days or less.
 薬浴への浸漬投与の場合、薬浴液中の有効成分の濃度は、例えば0.1から1000ppmである。最も好ましい濃度、時間は10mg/kg、2時間であるが、水温により効果および毒性が異なるため、魚の状態を観察しながら、調整することが必要である。投与は単回でもよく複数回でもよい。薬液浴中の有効成分の濃度、1回毎の浸漬時間、投与間隔は、対象となる魚類の薬物代謝状況に応じて適宜調整される。なお、投与間隔は、経口投与の場合と同様、一定であってもよく、各回毎に変化させてもよい。 In the case of immersion administration in a chemical bath, the concentration of the active ingredient in the chemical bath solution is, for example, 0.1 to 1000 ppm. The most preferable concentration and time are 10 mg / kg and 2 hours, but since the effect and toxicity differ depending on the water temperature, it is necessary to adjust while observing the state of the fish. Administration may be single or multiple. The concentration of the active ingredient in the chemical bath, the soaking time for each time, and the administration interval are appropriately adjusted according to the drug metabolism status of the target fish. In addition, the administration interval may be constant as in the case of oral administration, or may be changed every time.
 筋肉および腹腔内注射の場合、注射液中の有効成分の濃度は、例えば1mgから300mg/kgである。投与は単回でもよく複数回でもよい。最も好ましい濃度は10~100mg/kgであり、有効成分の濃度、投与間隔は、経口投与の場合と同様、一定であってもよく、各回毎に変化させてもよい。また、長期間持続的に血中濃度を維持させるため、カカオ油やアジュバント剤等と併用することが望ましい。 In the case of intramuscular and intraperitoneal injection, the concentration of the active ingredient in the injection solution is, for example, 1 mg to 300 mg / kg. Administration may be single or multiple. The most preferred concentration is 10 to 100 mg / kg, and the concentration of active ingredient and the administration interval may be constant as in the case of oral administration, or may be changed each time. Moreover, in order to maintain the blood concentration continuously for a long period of time, it is desirable to use it together with cacao oil or an adjuvant.
 次に、本発明の作用効果を確認するために行った実施例について説明する。
実施例1:ベコ病予防試験
1-1.フェンベンダゾールを用いたモジャコのベコ病予防試験
 予防試験は、下記の手順で行った。
 ・試験筏  5m×5m×5m
 ・試験尾数 1000尾(開始体重12g)
 ・投与方法 経口投与(展着剤とともに給餌)
 ・試験期間 6週間
 ・使用薬剤 フェンベンダゾール(上記式(1)で表される化合物)
 ・投与量  20mg/kg Bw(魚体重1kgあたり20mg)
 ・投与間隔 6回/週
Next, examples carried out for confirming the effects of the present invention will be described.
Example 1 Bacterial Disease Prevention Test 1-1. Mojaco's Boko Disease Prevention Test Using Fenbendazole The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 12g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 6 weeks Drug use Fenbendazole (compound represented by the above formula (1))
・ Dose 20mg / kg Bw (20mg per kg fish weight)
・ Dose interval 6 times / week
 サンプリング検査は、下記の手順で行った。
 投与開始後6週間目に、各試験区(対照区(給餌した飼料がフェンベンダゾールを含まない点を除き、上記の試験条件と同一の条件下で試験を行った。)、フェンベンダゾール区)よりモジャコ10尾ずつを取り上げ、3枚におろし、片身に微胞子虫のシスト(ベコシスト)が認められるかについて目視で検査した。ベコシストが認められた場合陽性と判定し集計した。肉眼で確認できたベコシストについて、数を確認し、1尾当たりの平均感染数を求めた。
Sampling inspection was performed according to the following procedure.
Six weeks after the start of administration, each test group (control group (test was conducted under the same conditions as described above except that the feed fed did not contain fenbendazole), fenbendazole group) ) 10 mojakos were taken out from each of them and dropped into 3 pieces, and it was visually inspected for microsporeworm cysts (becocysts) in one body. If becocyst was observed, it was determined as positive and counted. The number of becocysts confirmed with the naked eye was confirmed, and the average number of infections per fish was determined.
 検査結果を表1に示す。 Table 1 shows the inspection results.
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013
 感染数に関しては、対照区における陽性数が10尾中8尾であるのに対し、フェンベンダゾール区における陽性数は10尾中6尾であり、有意な差は認められなかった。一方、1尾当たりのベコシストの平均数は、対照区については、8.0±5.20個であるのに対し、フェンベンダゾール区では、3.5±3.83個であり、危険率5%以内で有意な差が認められた。 Regarding the number of infections, the number of positives in the control group was 8 out of 10, whereas the number of positives in the fenbendazole group was 6 out of 10 animals, and no significant difference was observed. On the other hand, the average number of becocysts per fish is 8.0 ± 5.20 for the control group, while it is 3.5 ± 3.83 for the fenbendazole group. Significant differences were observed within 5%.
1-2.フルベンダゾールを用いたモジャコのベコ病予防試験
 予防試験は、下記の手順で行った。
 ・試験筏  5m×5m×5m
 ・試験尾数 1000尾(開始体重12g)
 ・投与方法 経口投与(展着剤とともに給餌)
 ・試験期間 4週間
 ・使用薬剤 フルベンダゾール(上記式(6)で表される化合物)
 ・投与量  20mg/kg Bw(魚体重1kgあたり20mg)
 ・投与間隔 6回/週
 ・サンプリング検査手順:上記1-1.と同様
1-2. Mojaco's downy mildew prevention test using flubendazole The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 12g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 4 weeks Drug used Flubendazole (compound represented by the above formula (6))
・ Dose 20mg / kg Bw (20mg per kg fish weight)
・ Dose interval 6 times / week ・ Sampling test procedure: 1-1. the same as
 検査結果を表2に示す。 Table 2 shows the inspection results.
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014
 感染数に関しては、対照区では10尾中7尾で陽性が認められた一方で、フルベンダゾール区では10尾中5尾で陽性が認められた。この結果有意な差は認められなかった。一方、ベコシストの1尾当たりの平均は、対照区については、3.9±2.9個であり、フルベンダゾール区では、1.0±1.1個であった。この結果、対照区とフルベンダゾール区との間で、危険率5%以内で有意な差が認められた。 Regarding the number of infections, 7 out of 10 were positive in the control group, while 5 out of 10 were positive in the fulbendazole group. As a result, no significant difference was observed. On the other hand, the average per becocyst was 3.9 ± 2.9 for the control group and 1.0 ± 1.1 for the fulbendazole group. As a result, a significant difference was recognized within 5% between the control group and the fulbendazole group.
1-3.アルベンダゾールを用いた予防試験(1)
 予防試験は、下記の手順で行った。
 ・試験筏  5m×5m×5m
 ・試験尾数 1000尾(開始体重7g)
 ・投与方法 経口投与(展着剤とともに給餌)
 ・試験期間 2月間
 ・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
 ・投与量  20mg/kg Bw(魚体重1kgあたり20mg)
 ・投与間隔 6回/週
1-3. Prevention test using albendazole (1)
The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 7g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 2 months Drug Albendazole (compound represented by the above formula (3))
・ Dose 20mg / kg Bw (20mg per kg fish weight)
・ Dose interval 6 times / week
 サンプリング検査は、下記の手順で行った。
 投与開始から2週間毎に、各試験区よりモジャコを20尾(投与開始後8週目には100尾)ずつ取り上げ、3枚におろし、片身に微胞子虫のシスト(ベコシスト)が認められるかについて目視で検査する。ベコシストが認められた場合陽性と判定し集計する。肉眼で確認できたベコシストについて、数を確認し、1尾当たりの平均感染数を求める。
Sampling inspection was performed according to the following procedure.
Every 2 weeks from the start of administration, 20 mojaco (100 fish in the 8th week after the start of administration) are picked up from each test group, dropped into 3 pieces, and microsporeworm cysts (becocysts) are observed on one side Inspect visually. If becocyst is found, it is determined as positive and counted. The number of becocysts confirmed with the naked eye is confirmed, and the average number of infections per animal is determined.
 検査結果を表3に示す。 Table 3 shows the inspection results.
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015
 感染数に関しては、対照区において160尾中38尾の陽性が認められたのに対し、アルベンダゾール区は実施尾数160尾に対して1尾も陽性が認められなかった。この結果、今回の試験では養殖魚にベコ病の発生が0という驚くべき高い予防効果が認められた。 Regarding the number of infections, 38 out of 160 positives were found in the control group, whereas no positive was found in the albendazole group with respect to the number of 160 conducted. As a result, in this test, a surprisingly high preventive effect was observed that the occurrence of downy mildew in the cultured fish was zero.
 検査に供したモジャコの体重の推移を表4に示す。 Table 4 shows the changes in the weight of Mojaco subjected to the test.
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000016
 今回の試験の結果からは、アルベンダゾール区において、対照区と比較して有意な体重の増加が認められた。これは、ベコ病を発症しなかったため、ストレスを受けることなく、順調に成長したためと思われる。また、投与期間中のアルベンダゾール区において、対照区に対する斃死数の増加及び摂餌量の低下のいずれも認められなかった。また、この結果は、アルベンダゾールがモジャコの生育に有害な影響をもたらさないことを示唆している。 From the results of this test, a significant increase in body weight was observed in the albendazole group compared to the control group. This is probably because Beko's disease did not occur, and it grew smoothly without being stressed. In addition, in the albendazole group during the administration period, neither an increase in the number of deaths from the control group nor a decrease in food consumption was observed. This result also suggests that albendazole does not have a detrimental effect on the growth of Mojaco.
1-4.アルベンダゾールを用いた予防試験(2)
 アルベンダゾールの投与量を5、10mg/kg Bwに減少させた以外は、上記1-3.と同様の手順により、アルベンダゾールの投与及びサンプリング検査を行った。10mg/kg投与区では、投与開始後8週目のモジャコ100尾中、ベコシストの発生が確認された(陽性の)個体数は0であった。アルベンダゾールの投与量を5mg/kg Bwに減少させた場合、投与開始後8週目のモジャコ100尾中、3尾についてベコシストの発生が確認された。アルベンダゾールの投与量が5mg/kg Bwの場合、ベコシストの発生を完全に抑制することはできないが、対照区と比較して、ベコシストの発生は有意に抑制されている。
1-4. Prevention test using albendazole (2)
The above 1-3. Except that the dose of albendazole was reduced to 5, 10 mg / kg Bw. Albendazole administration and sampling test were performed according to the same procedure. In the 10 mg / kg administration group, the occurrence of becocysts was confirmed (positive) in 100 Mojaco fish 8 weeks after the start of administration. When the dose of albendazole was decreased to 5 mg / kg Bw, the occurrence of becocysts was confirmed in 3 out of 100 Mojaco 8 weeks after the start of administration. When the dose of albendazole is 5 mg / kg Bw, the occurrence of becocysts cannot be completely suppressed, but the occurrence of becocysts is significantly suppressed as compared with the control group.
1-5.アルベンダゾールを用いた予防試験(3)
 上記1-3.と同様の手順により、16週間にわたりアルベンダゾールの投与を継続すると共に、投与開始後2週目、4週目、6週目、8週目、12週目及び16週目にサンプリング検査を行った。アルベンダゾールの投与の終了から4週間後(投与開始から20週目)にも、同様の手順によりサンプリング検査を実施した。
1-5. Prevention test using albendazole (3)
1-3. In the same manner as above, the administration of albendazole was continued for 16 weeks, and sampling tests were performed at 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks and 16 weeks after the start of the administration. . Sampling test was performed by the same procedure 4 weeks after the end of the administration of albendazole (20 weeks after the start of administration).
 サンプリング検査の結果を表5に、16週間の全投与期間を通した感染率の集計結果を表6に、それぞれ示す。 The results of the sampling test are shown in Table 5, and the results of counting the infection rate over the entire administration period of 16 weeks are shown in Table 6, respectively.
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000018
 アルベンダゾール区では、アルベンダゾールの投与期間中、サンプリングしたすべての魚でベコシストが認められなかった。この結果、アルベンダゾールの投与を継続すれば、ベコ病をほぼ完璧に予防できることが示唆された。投与を終了して4週目にサンプリング検査したモジャコでも、ベコシストの発生は認められなかった。この結果より、投与を終了しても、少なくとも4週間は、アルベンダゾールによる微胞子虫の感染予防効果が持続することが確認された。 In the albendazole group, no becocyst was observed in all the fish sampled during the albendazole administration period. As a result, it was suggested that if the administration of albendazole is continued, beco's disease can be prevented almost completely. Even in Mojaco, which was sampled and tested 4 weeks after the end of administration, no becocyst was observed. From this result, it was confirmed that the effect of preventing the infection with microsporidia by albendazole lasted for at least 4 weeks even after the administration was completed.
1-6.アルベンダゾールを用いた予防試験(4)
 アルベンダゾールの1回あたりの投与量及び投与間隔の異なる2通りの投与方法を用いて予防試験を行った。予防試験は、下記の手順で行った。
 ・試験筏  5m×5m×5m
 ・試験尾数 1000尾(開始体重7g)
 ・投与方法 経口投与(展着剤とともに給餌)
 ・試験期間 6月間
 ・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
 ・投与量  試験区1:20mg/kg Bw(魚体重1kgあたり20mg)
       試験区2:40mg/kg Bw(魚体重1kgあたり40mg)
 ・投与間隔 試験区1:6回/週(16週間にわたり投与)
       試験区2:2回/2週(16週間にわたり投与)
1-6. Prevention test using albendazole (4)
A prophylaxis test was conducted using two different methods of administration of albendazole at different doses and intervals. The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 7g)
・ Administration method Oral administration (feeding with spreading agent)
Test period: 6 months Drugs used Albendazole (compound represented by the above formula (3))
・ Dose Test Section 1: 20 mg / kg Bw (20 mg per kg of fish body weight)
Test plot 2: 40 mg / kg Bw (40 mg / kg fish weight)
・ Dosing interval Test group 1: 6 times / week (administration over 16 weeks)
Study group 2: Twice / 2 weeks (administration over 16 weeks)
 サンプリング検査は、上記1-5.と同様の手順にしたがって行った。サンプリング検査の結果を下記の表7に示す。 Sampling inspection is as described in 1-5. The same procedure was followed. The results of the sampling test are shown in Table 7 below.
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000019
 アルベンダゾールの1回あたりの投与量及び投与間隔が、上記の1-1.と同様の試験区1では、アルベンダゾールの投与終了後8週間経過時までベコ病の感染の予防効果が持続せず、ベコシストの発生が確認されたが、試験区2では、アルベンダゾールの投与終了後8週間経過時(投与開始から24週目)においても、ベコシストの発生が大幅に抑制されていることが確認された。試験区2において確認されたベコシストは古く硬結したものであり、アルベンダゾールの投与後に新たに発生したものではないと考えられる。これらの結果より、試験区2において、試験区1と異なる投与方法でアルベンダゾールの投与を行うことにより、ベコ病の再感染に対する抵抗性が獲得されたことが示唆された。 The dose and administration interval of albendazole per time are as described in 1-1. In the same test group 1, the prevention of becopathic infection did not continue until 8 weeks after the end of the administration of albendazole, and the occurrence of becocysts was confirmed. In the test group 2, the end of the administration of albendazole It was confirmed that the occurrence of becocysts was greatly suppressed even after the lapse of 8 weeks (24 weeks after the start of administration). The becocysts confirmed in Test Zone 2 are old and hardened and are not considered to have newly occurred after the administration of albendazole. From these results, it was suggested that the resistance to reinfection of Beco's disease was acquired in Test Group 2 by administering albendazole by a different administration method from Test Group 1.
1-7.アルベンダゾールを用いた予防試験(5)
 モジャコの代わりにカンパチを用い、アルベンダゾールの投与によるベコ病の予防試験を行った。予防試験は、下記の手順で行った。
 ・試験筏  5m×5m×5m
 ・試験尾数 1000尾(開始体重50g)
 ・投与方法 経口投与(展着剤とともに給餌)
 ・試験期間 8週間
 ・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
 ・投与量  40mg/kg Bw(魚体重1kgあたり40mg)
 ・投与間隔 6回/週
 ・サンプリング検査手順:上記1-1.と同様
1-7. Prevention test using albendazole (5)
Using amberjack instead of Mojaco, a prophylaxis test for downy mildew by administration of albendazole was conducted. The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish 1000 (starting weight 50g)
・ Administration method Oral administration (feeding with spreading agent)
Test period 8 weeks Drug Albendazole (compound represented by the above formula (3))
・ Dose 40mg / kg Bw (40mg / kg fish weight)
・ Dose interval 6 times / week ・ Sampling test procedure: 1-1. the same as
 サンプリング検査の結果を下記の表8に示す。 The results of the sampling inspection are shown in Table 8 below.
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000020
 カンパチについても、アルベンダゾールの投与がベコシストの発生を有意に抑制することが確認された。 Also for amberjack, it was confirmed that the administration of albendazole significantly suppressed the occurrence of becocysts.
1-8.アルベンダゾールを用いた予防試験(6)
 トリクラベンダゾールを用いてカンパチのベコ病の予防試験を行った。予防試験は、下記の手順で行った。
 ・試験筏  5m×5m×5m
 ・試験尾数 1000尾(開始体重50g)
 ・投与方法 経口投与(展着剤とともに給餌)
 ・試験期間 8週間
 ・使用薬剤 トリクラベンダゾール(上記の式(10)で表される化合物)
 ・投与量  40mg/kg Bw(魚体重1kgあたり40mg)
 ・投与間隔 6回/週
 ・サンプリング検査手順:上記1-1.と同様
1-8. Prevention test using albendazole (6)
A prophylactic test for amberjack downy mildew was conducted using triclabendazole. The prevention test was conducted according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test animals 1000 (starting weight 50g)
・ Administration method Oral administration (feeding with spreading agent)
-Test period 8 weeks-Drugs used Triclabendazole (compound represented by the above formula (10))
・ Dose 40mg / kg Bw (40mg / kg fish weight)
・ Dose interval 6 times / week ・ Sampling test procedure: 1-1. the same as
 サンプリング検査の結果を下記の表9に示す。 The results of the sampling inspection are shown in Table 9 below.
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000021
 トリクラベンダゾールの投与がベコシストの発生を有意に抑制することが確認された。 It was confirmed that administration of triclabendazole significantly suppressed the generation of becocysts.
1-9.アルベンダゾールを用いた予防試験(7)
 ヒト、動物の一部の微胞子虫には、ベンズイミダゾール系の薬剤が効果を示すものがあり、これらの微胞子虫に対し、ベンズイミダゾール系の薬剤が第一選択薬として使用されている。作用機序としては、β-チューブリンのコドン198番目のグルタミン酸(E)に作用して、タンパク質生成を阻害する。ベンズイミダゾールの効果がない微胞子虫は198番目がグルタミン酸以外である。したがって、理論的には、魚介類の病原体である微胞子虫のβ-チューブリン遺伝子が、ベンズイミダゾール系の薬剤に感受性を示す微胞子虫のβ-チューブリン遺伝子と高い相同性を示すもの、さらには、コドン198番目がグルタミン酸であるものに対しては、ベンズイミダゾール系薬剤が、微胞子虫の防除用薬剤として可能性が高いと推測できる。そこで、種々の魚介類に対し感染性を示す微胞子虫からβ-チューブリン遺伝子を単離し、PCRによる増幅、シークエンシング及びアミノ酸配列の確認を行った。結果を下記の表10に示す。ヒト及びウサギ由来の微胞子虫のβ-チューブリンのアミノ酸配列は、Franzen C, Salzberger B Analysis of the beta-tubulin gene from Vittaforma corneae suggests benzimidazole resistance.Antimicrob Agents Chemother. 2008 Feb;52(2):790-3から引用した。
1-9. Prevention test using albendazole (7)
Some microsporeworms of humans and animals have an effect of benzimidazole drugs, and benzimidazole drugs are used as first-line drugs for these microsporeworms. As a mechanism of action, it acts on glutamic acid (E) at the 198th codon of β-tubulin to inhibit protein production. The 198th microsporeworm that does not have the effect of benzimidazole is other than glutamic acid. Therefore, in theory, the microsporeworm β-tubulin gene which is a pathogen of seafood shows a high homology with the microsporeworm β-tubulin gene sensitive to benzimidazole drugs, Furthermore, it can be presumed that a benzimidazole drug is highly likely to be a microsporeworm control drug for those whose codon 198 is glutamic acid. Therefore, the β-tubulin gene was isolated from microsporidia that were infectious to various fish and shellfish, amplified by PCR, sequencing and amino acid sequence confirmation. The results are shown in Table 10 below. The amino acid sequence of β-tubulin of human and rabbit microsporidia is Franzen C, Salzberger B Analysis of the beta-tubulin gene from Vittaforma corneae suggests benzimidazole resistance. Antimicrob Agents Chemother. 2008 Feb; 52 (2): 790 Quoted from -3.
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000022
  ベンズイミダゾール系薬剤に対する感受性が認められるウサギ由来微胞子虫のβ-チューブリンのアミノ酸配列と、ブリ、カンパチ、クロマグロ、マダイ及びホシガレイ由来のβ-チューブリンのアミノ酸配列との相同性は非常に高かった。さらに、これらの魚類に由来する微胞子虫のβ-チューブリン遺伝子コドン198は、すべてグルタミン酸(E)であった。上記試験結果よりこのため、マダイ由来、ホシガレイ由来、クロマグロ由来の微胞子中はベンズイミダゾールに感受性がある可能性が示唆された。 The amino acid sequence of β-tubulin from rabbit-derived microsporidia that is sensitive to benzimidazole drugs is highly homologous to the amino acid sequence of β-tubulin from yellowtail, amberjack, bluefin tuna, red sea bream, and flounder It was. Furthermore, the microsporeworm β-tubulin gene codon 198 derived from these fish was all glutamic acid (E). From the above test results, it was suggested that the microspores derived from red sea bream, hoshigarei and bluefin tuna may be sensitive to benzimidazole.
実施例2:治療試験
2-1.アルベンダゾールを用いたベコ病感染モジャコの治療試験
 治療試験は、下記の手順で行った。
 ・試験筏  5m×5m×5m
 ・試験尾数 100尾(ワクチン接種時の目視検査で明らかにベコ病に感染したことが認められた魚を選別して試験を実施)
 ・投与方法 経口投与(展着剤とともに給餌)
 ・試験期間 2月間
 ・使用薬剤 アルベンダゾール(上記の式(3)で表される化合物)
 ・投与量  50mg/kg Bw(魚体重1kgあたり50mg)
 ・投与間隔 6回/週
Example 2: Treatment test 2-1. Therapeutic test of downy mildew-infected mojaco using albendazole The therapeutic test was performed according to the following procedure.
・ Test cage 5m × 5m × 5m
・ Number of test fish: 100 (tests were conducted by selecting fish that were clearly infected with downy mildew by visual inspection at the time of vaccination)
・ Administration method Oral administration (feeding with spreading agent)
Test period 2 months Drug Albendazole (compound represented by the above formula (3))
・ Dose 50mg / kg Bw (50mg / kg fish weight)
・ Dose interval 6 times / week
検査方法
 ワクチン接種時の目視検査で、体表に凹凸が認められ、確実にベコが感染していることが認められるモジャコを選別して、無作為に対照区および試験区に分けた。投与開始後0日目、10日目、21日目に取り上げて、モジャコを3枚におろし、片身にベコシストが認められるかについて検査し、ベコ病シストが肉眼で認められた場合、陽性として集計した。
Examination method Mojaco with irregularities on the surface of the body and visual confirmation that Beko was infected by visual inspection at the time of vaccination was selected and randomly divided into a control group and a test group. Taken on the 0th, 10th, and 21st days after the start of administration, the mochaco was taken down to 3 sheets, tested for becocysts in one body, and positive if the becopathic cysts were observed with the naked eye Aggregated.
治療試験結果
 結果を表11に示す。
Treatment test results The results are shown in Table 11.
Figure JPOXMLDOC01-appb-T000023
Figure JPOXMLDOC01-appb-T000023
1)ベコ病シスト感染割合について
 外観からベコ病シストが認められたものを選別し、投薬試験を実施した後、ベコシストが認められた陽性数の集計結果を以下に示す。投薬10日目までは、感染割合に差が認められなかったが、21日間の投薬終了後の結果では、試験区において、63尾中28尾(44.4%)が陽性であったのに対して、対照区において、82尾中54尾(65.85%)であった。この結果危険率1%未満で有意な差が認められた。
1) Percentage of infection with becosis cysts After selecting those with becosis cysts from the appearance and conducting a dosing test, the results of counting the number of positive with becocysts are shown below. There was no difference in the infection rate up to the 10th day of dosing, but the results after 21 days of dosing were positive in 28 of 63 (44.4%) in the test group. In contrast, in the control group, it was 54 out of 82 (65.85%). As a result, a significant difference was recognized at a risk rate of less than 1%.

Claims (27)

  1.  下記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により下記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を有効成分として含む魚介類の微胞子虫の防除用組成物。
    Figure JPOXMLDOC01-appb-C000001
     なお、上記一般式(I)において、
     Rは、アミノ基、式-NH-COORで表される官能基、式-N=CHRで表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
     R、R、Rは、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
     Rは、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
     R、R、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
    Represented by the following general formula (I), preventing the infection of the microspores in the muscles or organs of seafood and / or suppressing the growth of microspores in the muscles or organs of seafood; and Compounds having activity to control microsporidia from the body of seafood, pharmaceutically acceptable salts thereof, and compounds that produce a compound represented by the following general formula (I) by metabolism in the body of seafood A composition for controlling microsporidia of fish and shellfish containing one or more selected from the group consisting of as active ingredients.
    Figure JPOXMLDOC01-appb-C000001
    In the general formula (I),
    R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
    R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
    R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
    R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
  2.  前記一般式(I)で表される化合物が、下記の式(1)から(7)及び(10)で表される化合物のいずれかであり、前記一般式(I)で表される化合物を生成する化合物が下記の式(8)及び(9)で表される化合物のいずれかである請求項1記載の魚介類の微胞子虫の防除用組成物。
    Figure JPOXMLDOC01-appb-C000002
    The compound represented by the general formula (I) is any one of the compounds represented by the following formulas (1) to (7) and (10), and the compound represented by the general formula (I): The composition for controlling microsporeworms of seafood according to claim 1, wherein the compound to be produced is any one of the compounds represented by the following formulas (8) and (9).
    Figure JPOXMLDOC01-appb-C000002
  3.  前記魚介類が、スズキ目(Perciformes)又はカレイ目(Pleuronectiformes)に属する魚類である請求項1又は2記載の魚介類の微胞子虫の防除用組成物。 3. The composition for controlling microspores of fish and shellfish according to claim 1 or 2, wherein the fish and shellfish are fish belonging to the order of Perciformes or Pleuronectiformes.
  4.  前記魚介類が、スズキ目サバ科(Scombridae)マグロ属(Thunnus)、スズキ目アジ科(Carangidae)ブリ属(Seriola)、スズキ目タイ科(Sparidae)マダイ属(Chrysophrys)、カレイ目ヒラメ科(Paralichthyidae)ヒラメ属(Paralichthys)又はカレイ目カレイ科(Pleuronectidae)マツカワ属(Verasper)に属する魚類である請求項3記載の魚介類の微胞子虫の防除用組成物。 The seafood includes Persian Scombridae (Thunnus), Persian Carridae (Seriola), Persian (Sparidae), Chrysophrys, Paralichthyidae (Paralichthyidae) 4. The composition for controlling microspores of fish and shellfish according to claim 3, which is a fish belonging to the genus Paralichthys or the genus Pleuronectidae or Verasper.
  5.  前記微胞子虫が、Microsporidium属に属する微胞子虫である請求項1から4のいずれか1項記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of seafood according to any one of claims 1 to 4, wherein the microspores are microsporidia belonging to the genus Microsporidium.
  6.  前記微胞子虫が、Microsporidium seriolaeである請求項5記載の魚介類の微胞子虫の防除用組成物。 6. The composition for controlling microspores of seafood according to claim 5, wherein the microsporeworm is Microsporidium seriolae.
  7.  経口投与剤である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of fish and shellfish according to any one of claims 1 to 6, which is an oral administration agent.
  8.  養魚用飼料である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling seafood microsporeworms according to any one of claims 1 to 6, which is a feed for fish farming.
  9.  注射剤である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of seafood according to any one of claims 1 to 6, which is an injection.
  10.  薬浴剤である請求項1から6のいずれか1項に記載の魚介類の微胞子虫の防除用組成物。 The composition for controlling microspores of fish and shellfish according to any one of claims 1 to 6, which is a bath salt.
  11.  下記の一般式(I)で表され、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除する活性を有する化合物、その薬学的に許容される塩及び魚介類の体内での代謝により前記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数を有効成分として含む組成物を魚介類に投与する工程を含む魚介類の微胞子虫の防除方法。
    Figure JPOXMLDOC01-appb-C000003
     なお、上記一般式(I)において、
     Rは、アミノ基、式-NH-COORで表される官能基、式-N=CHRで表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
     R、R、Rは、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
     Rは、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
     R、R、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
    Represented by the following general formula (I), preventing the infection of the microspores in the muscles or organs of seafood and / or suppressing the growth of microspores in the muscles or organs of seafood; and / Or a compound having an activity to control microsporidia from the body of fish and shellfish, a pharmaceutically acceptable salt thereof, and a compound that generates the compound represented by the general formula (I) by metabolism in the body of fish and shellfish A method for controlling microsporeworms of fish and shellfish, comprising a step of administering to the fish and shellfish a composition comprising one or more selected from the group consisting of as active ingredients.
    Figure JPOXMLDOC01-appb-C000003
    In the general formula (I),
    R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
    R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
    R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
    R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
  12.  前記一般式(I)で表される化合物が、下記の式(1)から(7)及び(10)で表される化合物のいずれかであり、前記一般式(I)で表される化合物を生成する化合物が下記の式(8)及び(9)で表される化合物のいずれかである請求項11記載の魚介類の微胞子虫の防除方法。
    Figure JPOXMLDOC01-appb-C000004
    The compound represented by the general formula (I) is any one of the compounds represented by the following formulas (1) to (7) and (10), and the compound represented by the general formula (I): The method for controlling microsporeworms of fish and shellfish according to claim 11, wherein the compound to be produced is one of the compounds represented by the following formulas (8) and (9).
    Figure JPOXMLDOC01-appb-C000004
  13.  前記魚介類が、スズキ目(Perciformes)又はカレイ目(Pleuronectiformes)に属する魚類である請求項11又は12記載の魚介類の微胞子虫の防除方法。 13. The method for controlling microspores of seafood according to claim 11 or 12, wherein the seafood is a fish belonging to the order Perciformes or Pleuronectiformes.
  14.  前記魚介類が、スズキ目サバ科(Scombridae)マグロ属(Thunnus)、スズキ目アジ科(Carangidae)ブリ属(Seriola)、スズキ目タイ科(Sparidae)マダイ属(Chrysophrys)、カレイ目ヒラメ科(Paralichthyidae)ヒラメ属(Paralichthys)又はカレイ目カレイ科(Pleuronectidae)マツカワ属(Verasper)に属する魚類である請求項13記載の魚介類の微胞子虫の防除方法。 The seafood includes Persian Scombridae (Thunnus), Persian Carridae (Seriola), Persian (Sparidae), Chrysophrys, Paralichthyidae (Paralichthyidae) 14. The method for controlling microspores of fish and shellfish according to claim 13, which is a fish belonging to the genus Paralichthys or the genus Pleuronectidae or Verasper.
  15.  前記微胞子虫が、Microsporidium属に属する微胞子虫である請求項11から14のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microspores of fish and shellfish according to any one of claims 11 to 14, wherein the microspores are microspores belonging to the genus Microsporidium.
  16.  前記微胞子虫が、Microsporidium seriolaeである請求項15記載の魚介類の微胞子虫の防除方法。 The method of controlling a microspore of a seafood according to claim 15, wherein the microsporidia is Microsporidium seriolae.
  17.  前記魚介類への投与が経口投与である請求項11から16のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microsporeworms of seafood according to any one of claims 11 to 16, wherein the administration to the seafood is oral administration.
  18.  請求項7又は8記載の魚介類の微胞子虫の防除用組成物を、その有効成分の用量が0.1mg/kg以上100mg/kg以下となるよう、単回或いは1日以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫感染を予防する請求項17記載の魚介類の微胞子虫の防除方法。 The composition for controlling microspores of fish and shellfish according to claim 7 or 8, wherein the dose of the active ingredient is 0.1 mg / kg or more and 100 mg / kg or less at a single time or 1 day or more and 180 days or less. The method for controlling microsporeworms of seafood according to claim 17, wherein the microsporeworm infection of seafood is prevented by oral administration multiple times at intervals.
  19.  請求項7又は8記載の魚介類の微胞子虫の防除用組成物を、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、単回或いは6時間以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫を駆除する請求項17記載の魚介類の微胞子虫の防除方法。 9. The composition for controlling microspores of seafood according to claim 7 or 8, wherein the dose of the active ingredient is 20 mg / kg or more and 400 mg / kg or less at a single time or at intervals of 6 hours or more and 180 days or less. 18. The method for controlling seafood microsporeworms according to claim 17, wherein the microsporeworms of seafood are controlled by oral administration multiple times.
  20.  請求項7又は8記載の魚介類の微胞子虫の防除用組成物を、その有効成分の用量が20mg/kg以上400mg/kg以下となるよう、3日以上180日以下の間隔で複数回経口投与することにより魚介類の微胞子虫の駆除及び再感染の予防を行う請求項17記載の魚介類の微胞子虫の防除方法。 9. The composition for controlling microspores of seafood according to claim 7 or 8, wherein the active ingredient dose is 20 mg / kg or more and 400 mg / kg or less at an interval of 3 days or more and 180 days or less. The method for controlling microspores of fish and shellfish according to claim 17, wherein the microsporeworms of fish and shellfish are controlled and reinfection is prevented by administration.
  21.  前記魚介類の微胞子虫の防除用組成物を、5日以上21日以下の間隔で経口投与することを特徴とする請求項20記載の魚介類の微胞子虫の防除方法。 The method for controlling microspores of fish and shellfish according to claim 20, wherein the composition for controlling microspores of fish and shellfish is orally administered at intervals of 5 days or more and 21 days or less.
  22.  前記複数回の経口投与を1サイクルとし、前記サイクルを、3日以上180日以下の間隔で反復することを特徴とする請求項20又は21記載の魚介類の微胞子虫の防除方法。 The method for controlling microspores of fish and shellfish according to claim 20 or 21, wherein the plurality of oral administrations are defined as one cycle, and the cycle is repeated at intervals of 3 days or more and 180 days or less.
  23.  前記魚介類への投与が筋肉注射又は腹腔内注射である請求項11から16のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microsporeworms of seafood according to any one of claims 11 to 16, wherein the administration to the seafood is intramuscular injection or intraperitoneal injection.
  24.  前記魚介類への投与が薬浴中での浸漬投与である請求項11から16のいずれか1項記載の魚介類の微胞子虫の防除方法。 The method for controlling microsporeworms of fish and shellfish according to any one of claims 11 to 16, wherein the fish and shellfish are administered by immersion in a medicine bath.
  25.  請求項10記載の魚介類の微胞子虫の防除用組成物を、その有効成分の濃度が1から1000ppmとなる量だけ含有している薬浴液中で、魚介類への浸漬投与を行う請求項24記載の魚介類の微胞子虫の防除方法。 Claims for immersing administration to seafood in a medicinal bath solution containing the composition for controlling microspores of seafood according to claim 10 in an amount such that the concentration of the active ingredient is 1 to 1000 ppm. Item 25. A method for controlling microspores of seafood according to Item 24.
  26.  下記の一般式(I)で表される化合物及びその薬学的に許容される塩、並びに魚介類の体内での代謝により下記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数の、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除するための使用。
    Figure JPOXMLDOC01-appb-C000005
     なお、上記一般式(I)において、
     Rは、アミノ基、式-NH-COORで表される官能基、式-N=CHRで表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
     R、R、Rは、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
     Rは、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
     R、R、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
    From the group consisting of a compound represented by the following general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that produces a compound represented by the following general formula (I) by metabolism in the body of fish and shellfish Prevention of infection of microsporeworms in one or more selected muscles or organs of seafood and / or suppression of microsporeworm growth in muscles or organs of seafood and / or seafood Use to control microsporidia from the body of moss.
    Figure JPOXMLDOC01-appb-C000005
    In the general formula (I),
    R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
    R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
    R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
    R 8, R 9, R 10 , R 11, R 12 are each independently an alkyl group, a cycloalkyl group, an alkoxyl group, an aryl group, a heteroaryl group, a substituted acyl group, a substituted alkyl group, a substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.
  27.  下記の一般式(I)で表される化合物及びその薬学的に許容される塩、並びに魚介類の体内での代謝により下記一般式(I)で表される化合物を生成する化合物からなる群より選択される1又は複数の、魚介類の筋肉又は臓器への微胞子虫の感染を予防し、かつ/又は魚介類の筋肉又は臓器中での微胞子虫の増殖を抑制し、かつ/又は魚介類の体内から微胞子虫を駆除するための防除用組成物の製造における有効成分としての使用。
    Figure JPOXMLDOC01-appb-C000006
     なお、上記一般式(I)において、
     Rは、アミノ基、式-NH-COORで表される官能基、式-N=CHRで表される官能基、式-N=CR10(R11)で表される官能基、2-チアゾリル基、アルキルチオ基からなる群より選択される官能基であり、
     R、R、Rは、それぞれ独立して、水素原子、ハロゲン原子、ニトロ基、スルホン酸基、カルボキシル基、シアノ基、アシル基、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、アリールオキシ基、ヘテロアリールオキシ基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基、置換アリールオキシ基、置換ヘテロアリールオキシ基からなる群より選択される原子又は官能基であり、
     Rは、水素原子、アミノ基、式-NH-COOR12で表される官能基、アルコキシル基、アルキルチオ基、アリールチオ基、アルキルスルホキシド基、アリールスルホキシド基、アシル基、置換アルコキシル基、置換アルキルチオ基、置換アルキルスルホキシド基、置換アリールスルホキシド基、置換アシル基、ハロゲン基、アリールオキシ基、置換アリールオキシ基及びR13-CO-NH-(R13はアルキル基)からなる群より選択される原子又は官能基であり、
     R、R、R10、R11、R12は、それぞれ独立して、アルキル基、シクロアルキル基、アルコキシル基、アリール基、ヘテロアリール基、置換アシル基、置換アルキル基、置換シクロアルキル基、置換アルコキシル基、置換アリール基、置換ヘテロアリール基からなる群より選択される原子又は官能基である。
     
     
    From the group consisting of a compound represented by the following general formula (I) and a pharmaceutically acceptable salt thereof, and a compound that produces a compound represented by the following general formula (I) by metabolism in the body of fish and shellfish Prevention of infection of microsporeworms in one or more selected muscles or organs of seafood and / or suppression of microsporeworm growth in muscles or organs of seafood and / or seafood Use as an active ingredient in the manufacture of a control composition for controlling microsporidia from the body of mosses.
    Figure JPOXMLDOC01-appb-C000006
    In the general formula (I),
    R 2 represents an amino group, a functional group represented by the formula —NH—COOR 8 , a functional group represented by the formula —N═CHR 9 , a functional group represented by the formula —N═CR 10 (R 11 ), A functional group selected from the group consisting of a 2-thiazolyl group and an alkylthio group,
    R 4 , R 6 and R 7 are each independently a hydrogen atom, halogen atom, nitro group, sulfonic acid group, carboxyl group, cyano group, acyl group, alkyl group, cycloalkyl group, alkoxyl group, aryl group, From heteroaryl group, aryloxy group, heteroaryloxy group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group, substituted alkoxyl group, substituted aryl group, substituted heteroaryl group, substituted aryloxy group, substituted heteroaryloxy group An atom or functional group selected from the group consisting of
    R 5 represents a hydrogen atom, an amino group, a functional group represented by the formula —NH—COOR 12 , an alkoxyl group, an alkylthio group, an arylthio group, an alkyl sulfoxide group, an aryl sulfoxide group, an acyl group, a substituted alkoxyl group, or a substituted alkylthio group. An atom selected from the group consisting of a substituted alkyl sulfoxide group, a substituted aryl sulfoxide group, a substituted acyl group, a halogen group, an aryloxy group, a substituted aryloxy group and R 13 —CO—NH— (wherein R 13 is an alkyl group), Functional group,
    R 8 , R 9 , R 10 , R 11 , R 12 are each independently an alkyl group, cycloalkyl group, alkoxyl group, aryl group, heteroaryl group, substituted acyl group, substituted alkyl group, substituted cycloalkyl group , A substituted alkoxyl group, a substituted aryl group, or a substituted heteroaryl group.

PCT/JP2017/013489 2016-03-31 2017-03-30 Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same WO2017170970A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2017239880A AU2017239880B2 (en) 2016-03-31 2017-03-30 Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same
US16/089,226 US10813914B2 (en) 2016-03-31 2017-03-30 Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same
KR1020187030805A KR20180125565A (en) 2016-03-31 2017-03-30 A composition for controlling microorganisms and a method for controlling microorganisms
EP17775503.0A EP3437642A4 (en) 2016-03-31 2017-03-30 Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same
MX2018011974A MX2018011974A (en) 2016-03-31 2017-03-30 Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same.
CN201780021272.1A CN108883095B (en) 2016-03-31 2017-03-30 Composition for controlling scale-like microsporidian, and method for controlling scale-like microsporidian using same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2016-070840 2016-03-31
JP2016070840 2016-03-31
JP2017-047531 2017-03-13
JP2017047531A JP6343796B2 (en) 2016-03-31 2017-03-13 Composition for controlling microspores of seafood and method for controlling microspores of seafood using the same

Publications (1)

Publication Number Publication Date
WO2017170970A1 true WO2017170970A1 (en) 2017-10-05

Family

ID=59965949

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/013489 WO2017170970A1 (en) 2016-03-31 2017-03-30 Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same

Country Status (1)

Country Link
WO (1) WO2017170970A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57106621A (en) * 1980-12-24 1982-07-02 Takeda Chem Ind Ltd Preventing agent and remedy for fish disease
JP2002220309A (en) * 2001-01-29 2002-08-09 Kyowa Hakko Kogyo Co Ltd Exterminator and exterminating method of benedenia
JP2004511471A (en) * 2000-10-06 2004-04-15 バイエル アクチェンゲゼルシャフト N-alkoxyalkyl-substituted benzimidazoles and their use as drugs against parasitic protozoa

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57106621A (en) * 1980-12-24 1982-07-02 Takeda Chem Ind Ltd Preventing agent and remedy for fish disease
JP2004511471A (en) * 2000-10-06 2004-04-15 バイエル アクチェンゲゼルシャフト N-alkoxyalkyl-substituted benzimidazoles and their use as drugs against parasitic protozoa
JP2002220309A (en) * 2001-01-29 2002-08-09 Kyowa Hakko Kogyo Co Ltd Exterminator and exterminating method of benedenia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SCHMAHL G. ET AL.: "Treatment of fish parasites. 11. Effects of different benzimidazole derivatives (albendazole, mebendazole, fenbendazole) on Glugea anomala, Moniez, 1887 (Microsporidia): Ultrastructural aspects and efficacy studies", PARASITOLOGY RESEARCH, vol. 84, no. 1, 1 February 1998 (1998-02-01), pages 41 - 49, XP055578950 *
See also references of EP3437642A4 *

Similar Documents

Publication Publication Date Title
JP6565075B2 (en) Therapeutic composition for oral administration of fish and shellfish beko disease and method for treating fish and shellfish beko disease using the same
TWI488625B (en) Use of fungicides for the treatment of fish mycoses
JP6784866B1 (en) A therapeutic agent for diseases caused by microsporidia and myxosporea parasitizing marine fish
KR101317083B1 (en) Parasite control agent for fish, and parasite control method for fish
JP5771203B2 (en) Fish parasite control agent and control method
US9265777B2 (en) Antiparasitic agent for fish and method of controlling proliferation of fish parasites
US20150272931A1 (en) New Treatment
JPS6339569B2 (en)
WO2017170970A1 (en) Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same
JPH07188009A (en) Anti-coccidium composition
JP7424983B2 (en) How to prevent muscle melting in salmonids
JP4695766B2 (en) Fish parasite control agent and control method
JPH07103036B2 (en) Method for preventing and treating nodular disease of fish
JPS6160041B2 (en)

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: MX/A/2018/011974

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20187030805

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2017239880

Country of ref document: AU

Date of ref document: 20170330

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2017775503

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2017775503

Country of ref document: EP

Effective date: 20181031

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17775503

Country of ref document: EP

Kind code of ref document: A1